Sample Internship Training Plan Template

Internship Manual
Updated February 2018
To be reviewed by the preceptor and intern.

College of Pharmacists of Manitoba
200 Tache Avenue, Winnipeg, Manitoba R2H 1A7
Phone (204) 233-1411 | Fax: (204) 237-3468
E-mail: [email protected] | Website: www.cphm.ca
Note:
All preceptors must have a minimum of 2 years of licensure immediately prior to the date of the
preceptor application in the province of Manitoba.
The internship may be completed at the intern’s site of choice, as long as no conflict of interest
exists, or has been declared to and approved by the registrar. A conflict of interest exists if
there is a family relation, personal relationship, or any other factor that could be perceived as
potentially compromising an objective, candid and fair assessment of the candidate’s
competency. This criterion applies to all pharmacists, pharmacy staff and managers at the site.
In a motion passed at the April 25, 2003 Council meeting, immediate family members, including
parents, children, husbands, wives, aunts, uncles, grandparents, grandchildren, sisters, brothers
and in-laws shall not serve as preceptors for other family members.
This Internship Manual contains information and exercises to be discussed during the
internship program.
The answers to the scenarios at the end of this manual do not need to be forwarded to the
College. They are for discussion purposes only. The intern must make notes about the issues
discussed and is encouraged to keep them for future reference. The recorded answers may be
requested for review by the Board of Examiners or the Registrar, and must be kept on file for at
least one year by the intern.
Preceptors are required to send the Evaluation Forms to the College during the internship
process. The reports are sent after each third of the total internship period (i.e., every 120
hours for a 360 hour internship and every 200 hours for a 600 hour internship). The final signed
statement indicating the intern has successfully (or unsuccessfully) completed the internship
program is the final step in the internship process.
College of Pharmacists of Manitoba Mission:

To protect the health and well being of the public by ensuring and
promoting safe, patient-centred and progressive pharmacy practice.
Member of the National Association of Pharmacy Regulatory Authorities
Phone (204) 233-1411 | Fax: (204) 237-3468
Dear Preceptor:
Thank you for participating in the final portion of the structured practical training that will qualify international pharmacy
graduates as well as new graduates, for licensure with The College of Pharmacists of Manitoba. The internship program is a
process to incorporate the skills and knowledge, taught through the University programs, into the practice site.
You are to be congratulated for fulfilling a professional obligation to train new graduates and facilitate their transition to
becoming a professional pharmacist. It is important to remember that as a preceptor, you will have a lasting impact upon the
intern. The practice information provided may help the intern through some of the difficult times associated with entering into
professional practice.
This is an opportunity for the intern to learn from an experienced practicing professional using their knowledge, training and
experience to enhance patient care and work with other professionals on the healthcare team. The preceptor and intern are
encouraged to ask questions and discuss issues beyond what is contained in the Internship Manual.
An important part of the internship program is to validate the intern’s communication skills. Under the Language Fluency
Requirements for Licensure, the preceptor is obligated to verify that the intern’s language fluency is adequate. The Board of
Examiners now requires a minimum of 400 hours to be served in a pharmacy that has direct contact with patients. If your
practice site cannot meet this requirement, please contact me directly so additional arrangements can be made.
This Internship Manual was updated extensively and contains information and exercises to be completed during the internship
program. The answers to the scenarios at the end of this manual do not need to be forwarded to the College; they are for
discussion and learning purposes only. The intern must make notes about the issues raised during discussion and keep them for
future reference. The recorded answers may be requested for review by the Board of Examiners or myself, and must be kept on
file for at least one year by the intern.
Preceptors are required to forward the three Evaluation Forms during the internship process. The final signed statement
indicating the intern has successfully, or unsuccessfully, completed the internship program is the final step in the internship
process. Be advised, the preceptor also has an option to request a second opinion. By signing the report stating the intern has
completed the internship program successfully, you are taking responsibility that the intern is now able to practice in Manitoba.
This responsibility is not to be taken lightly.
The College of Pharmacists of Manitoba’s Council approved serving as a preceptor for pharmacy students, residents, interns and
technicians to be an accredited learning activity for pharmacists in Manitoba. Included with this manual is a letter outlining how
pharmacists must document their significant learning experiences gained as a preceptor in their online PD Log and the associated
contact time. Also included is an accreditation statement that should be kept in your Learning Portfolio as a record of your involvement
as a preceptor.
Once again, thank you for your participation.
Susan Lessard-Friesen, B.Sc. (Pharm.)

Registrar
College of Pharmacists of Manitoba Mission:

To protect the health and well being of the public by ensuring and
promoting safe, patient-centred and progressive pharmacy practice.
Member of the National Association of Pharmacy Regulatory Authorities
CONTENTS
Introduction .......................................................................................................................... 5
Expanded Pharmacy Practice Roles ........................................................................................ 8
Objectives of the Postgraduate Internship Program ............................................................. 10
Program Overview and Requirements ................................................................................. 11
Application and Registration .............................................................................................................. 11
Internship Manual .............................................................................................................................. 11
Preceptorship...................................................................................................................................... 11
Attendance ......................................................................................................................................... 12
Post-Graduation.................................................................................................................................. 12
Evaluation ........................................................................................................................................... 12
Unsuccessful Completion ................................................................................................................... 13
Intern Responsibilities ......................................................................................................... 14
Preceptor Responsibilities ................................................................................................... 16
The College of Pharmacists of Manitoba .............................................................................. 18
Orientation to the Pharmacy ............................................................................................... 20
Community Pharmacy ........................................................................................................................ 20
Hospital Pharmacy .............................................................................................................................. 23
Professional Competencies for Canadian Pharmacists at Entry to Practice ............................ 25
1. Ethical, Legal and Professional Responsibilities.............................................................................. 26
2. Patient Care .................................................................................................................................... 28
3. Product Distribution ....................................................................................................................... 33
4. Practice Setting ............................................................................................................................... 39
5. Health Promotion ........................................................................................................................... 42
6. Knowledge and Research Application ............................................................................................ 43
7. Communication and Education ...................................................................................................... 44
8. Intra- and Inter-Professional Collaboration .................................................................................... 46
9. Quality and Safety........................................................................................................................... 49
Conclusion........................................................................................................................................... 52
Intern’s Self-Assessment and Personal Learning Plan ........................................................... 53
Feedback and Review of Learning Goals ............................................................................................ 62
Personal Learning Plan ....................................................................................................................... 63
Demonstration of Product Release Proficiency..................................................................... 64
Case Scenarios and Questions for the Intern ........................................................................ 71
A. College Assignment ........................................................................................................................ 72
B. Pharmaceutical Care Plans Assignment.......................................................................................... 75
C. Communication Assignment........................................................................................................... 77
D. Non-Prescription Drug Assignment ................................................................................................ 80
E. Community Pharmacy Assignment ................................................................................................. 83
F. Hospital Pharmacy Assignment ...................................................................................................... 87
Checklist for Completion of Internship Program ................................................................... 91
Evaluation Forms ................................................................................................................. 92
Evaluation Form #1 ............................................................................................................................. 93
3
Evaluation Form #2 ........................................................................................................................... 102
Final Evaluation Form ....................................................................................................................... 111
Intern’s Evaluation of the Preceptor ................................................................................................ 120
Intern’s Feedback on the Internship Program .................................................................................. 121
Preceptor’s Feedback on the Internship Program ............................................................................ 122
Statement of Completion of Internship............................................................................................ 123
Letter to Preceptors from the College of Pharmacists of Manitoba ..................................... 124
Statement of Participation ............................................................................................................... 125
*Forms to be submitted ONLINE through the preceptor and intern’s member profiles to the College*
4
Introduction
The primary purpose of the internship period is to prepare the graduate for the practice of
pharmacy in an active patient-care setting. Beginning January 1, 2014, all internship applicants
must serve an internship period of 600 hours to be completed in a period of not less than 15
and not greater than 21 weeks. For graduates of the College of Pharmacy, University of
Manitoba, 240 hours of the internship period can be completed while registered as an intern in
the Structured Practical Experiential Program (SPEP). An intern cannot work more than 8 hours
per day or more than 40 hours per week at the pharmacy. The intern must complete a
minimum of 400 hours of direct patient care within the pharmacy. An internship provides
opportunities to apply the education and competencies obtained in a pharmacy degree, as well
as an opportunity to apply the model standards of practice. It is recognized that the knowledge,
skills and attitudes gained in the completion of a pharmacy program will provide the foundation
for all categories of competencies as noted in NAPRA’s 2014 Professional Competencies for
Canadian Pharmacists at Entry to Practice:
1. Ethical, Legal and Professional Responsibilities

Pharmacists practice within legal requirements, demonstrate professionalism and
uphold professional standards of practice, codes of ethics, and policies.
2. Patient Care
Pharmacists, in partnership with patients and in collaboration with other healthcare
professionals, meet the patients’ drug-related needs and to achieve the patient’s health
goals.
3. Product Distribution
Pharmacists ensure accurate product distribution that is safe and appropriate for the
patient.
4. Practice Setting
Pharmacists oversee the practice setting with the goal of ensuring safe, effective and
efficient patient care.
5. Health Promotion
Pharmacists use their expertise to advance the health and wellness of patients,
communities and populations.
6. Knowledge and Research Application
Pharmacists access, retrieve, critically analyze and apply relevant information to make
evidence-informed decisions within their practice with the goal of ensuring safe and
effective patient care.
7. Communication and Education
Pharmacists communicate effectively with patients, the pharmacy team, other health
professionals and the public, providing education when required.
Introduction 5
8. Intra and Inter-Professional Collaboration
Pharmacists work in collaboration with the pharmacy team and other health
professionals to deliver comprehensive services, make best use of resources and ensure
continuity of care in order to achieve the patient’s health goals.
9. Quality and Safety
Pharmacists collaborate in developing, implementing, and evaluating policies,
procedures and activities that promote quality and safety.
Not every pharmacist performs within each of these competencies as part of their daily
practice. When a pharmacist performs a specific competency or role, he/she must meet all
minimum standards of practice consistent with that role. NAPRA has created the Model
Standards of Practice for Canadian Pharmacists that are required of all pharmacists regardless
of the type of role or pharmacy practice they are fulfilling. These are standards against which a
pharmacist’s performance can be judged when the pharmacist is undertaking the activities
required for safe and effective pharmacy practice. Generally, the four domains and general
standards that all pharmacists must meet are as follows:
1. Expertise in medications and medication-use

 Pharmacists maintain their competence.
 Pharmacists apply their medication and medication-use expertise while performing
their daily activities.
 Pharmacists provide evidence of application of their medication and medication-use
expertise through documentation.
2. Collaboration
 Pharmacists work constructively with students, peers and members of the inter-
professional team.
 Pharmacists communicate effectively.
3. Safety and Quality

 Pharmacists undertake continuing professional development, quality assurance and
quality improvement.
 Pharmacists respond to safety risks.
4. Professionalism and Ethics

 Pharmacists demonstrate professionalism and apply ethical principles in their daily
work.
Introduction 6
The learning objectives, suggested learning activities, and evaluations of the internship program
will revolve around the competencies and model standards that are applicable to the
internship. The 2014 Professional Competencies for Canadian Pharmacists at Entry to Practice
and Model Standards of Practice for Canadian Pharmacists documents can be viewed in their
entirety at NAPRA’s website, www.napra.ca.
The education received during the internship is accomplished by a combination of explanation,

repetitive practice and constructive criticism from an experienced preceptor. For the success of
the program, it is important that the intern perform the procedures (under the guidance of the
preceptor) that will be expected of them once they are licensed, along with the learning
activities that are provided in the manual.
Preceptors are encouraged to add additional activities to ensure the intern is prepared and able
to begin a career of safe and effective pharmacy practice. The internship assessment is the final
step in the process from academia to practice. The preceptor’s role is critical in assessing the
intern’s competency and protecting the public.
Introduction 7
Expanded Pharmacy Practice Roles
Under the December 2006 Pharmaceutical Act and the new Pharmaceutical Regulations (which
came into effect January 1, 2014) the scope of pharmacy practice has expanded to include new
roles for all licensed pharmacists, including:
 Prescribing a non-prescription (Schedule II or III) drug or medical device.
 Adapting a prescription in relation to dosage strength, dosage interval or formulation.
 Administering drugs orally, topically or via inhalation.
 Interpreting patient-administered automated tests.
Pharmacists that receive additional knowledge, training, and authorization from the College
may:
 Prescribe drugs for Schedule 3 (self-limiting) conditions.
o Schedule 3 to the Regulation of the Pharmaceutical Act lists the conditions for
which prescription-only drugs can be prescribed by a pharmacist.
 Administer a drug via injection.
 Order the results of a screening or diagnostic test specified in Schedule 1 to the

Regulation, in relation to a drug prescribed to the patient.
 Apply for registration as an extended practice pharmacist.

o Members registered as an extended practice pharmacist have additional
prescribing authority for Schedule I drugs within the scope of their speciality.
Practice directions for each of these new practice roles have been developed and implemented
to provide pharmacists with guidelines to follow. All practice directions, standards of practice
and practice guidelines and can be viewed on the College website.
The Guide to Pharmacy Practice in Manitoba, practice directions and standards of practice
should be reviewed by the preceptor and intern. The legislation should be discussed by the
preceptor and pharmacy intern to ensure understanding of the recent changes in the scope of
pharmacy practice.
All graduates from the College of Pharmacy at the University of Manitoba receive training to
administer drugs through injection (graduates of 2014 and later) and to prescribe drugs for self-
limiting (Schedule 3) conditions. If the preceptor pharmacist has received a Certificate of
Authorization to Administer Drugs and Vaccines by Injection and/or a Certificate of
Authorization to Prescribe a drug included in Schedule 3 (or another pharmacist is qualified at
the practice site), the intern can perform these practices under the guidance of the certified
Expanded Pharmacy Practice Roles 8

pharmacist. The intern should be reminded that, upon being licensed by the College, the intern
must apply to the College of Pharmacists of Manitoba (College) in order to receive
authorization to perform these additional practices.
Expanded Pharmacy Practice Roles 9

Objectives of the Postgraduate Internship Program
The primary objective of the postgraduate training period is to assess the knowledge and skills
learned in the undergraduate pharmacy program, and to develop skills in providing
pharmaceutical care in the real world setting. The following objectives are part of, and support,
the provision of pharmaceutical care along with the competencies and standards of practice:
 Maintain the patient medication profile, evaluate therapy, interpret and evaluate new
prescriptions, identify drug related problems and formulate recommendations to
resolve potential and existing problems.
 Accurately dispense medication according to the prescription and ensure patient safety.
 Counsel patients on the use of their prescribed medication and assist patients on the
selection, use, and effects of non-prescription medications.
 Communicate with patients and health professionals regarding drug information and
therapeutic goals and outcomes.
 Comply with all legal requirements associated with the distribution of drugs and the
operation of a pharmacy.
 Provide information and/or referral services (when appropriate) in emergencies, and
upon request.
 Develop and exercise professional judgement.
 Be knowledgeable of, and maintain ethical and professional practice and comply with
the rules and standards governing practice.
 Develop self-assessment skills and take responsibility for lifelong learning and
professional development in pharmacy.
 Understand the practice requirements for performing the included practices
(prescribing, administration of drugs, test ordering and interpretation).
 Be knowledgeable of the role of a pharmacy technician and other persons.
 Ensure patient confidentiality in compliance with the Personal Health Information Act.
Objectives 10
Program Overview and Requirements
Application and Registration
 Every person desirous of becoming a pharmacy intern shall apply to the Registrar of the
College of Pharmacists of Manitoba, and upon approval, shall:
1. Pay a registration fee.
2. Furnish satisfactory evidence to the Registrar of having completed the 4 th year of
the pharmacy program at the University of Manitoba, or another recognized
education program.
 Once commenced, an internship of 600 hours must be completed in a period of not less
than 15 weeks and not greater than 21 weeks. An internship of 360 hours is to be
completed in a period of not less than 9 and not greater than 15 weeks.
Internship Manual
 The internship program shall be based upon this Internship Manual provided by the College
to the preceptor pharmacist and the pharmacy intern.
 The Internship Manual contains the procedures, assignments and evaluations for the
program.
 Council shall reserve the right to review, modify or amend the manual and evaluation
procedures as it deems appropriate.
Preceptorship
 The internship shall be served in a licensed pharmacy under the supervision of a licensed
pharmacist approved by Council as a preceptor pharmacy and a preceptor pharmacist. The
intern shall be responsible for securing a preceptor pharmacist and preceptor pharmacy.
 The intern shall apply to the Registrar, at least 7 days prior to commencement of the
internship, including the name of the preceptor pharmacist and the location of the
preceptor pharmacy.
o Any changes in preceptor pharmacist and/or pharmacy will require the approval of
the Registrar in advance.
 A licensed pharmacist shall be deemed eligible to train an intern if, in addition to
compliance with the Manitoba Pharmaceutical Act, the preceptor pharmacist:
o Has been approved by Council as a preceptor,
o Has satisfied Council that the preceptor will provide ample time with the intern to
allow the intern to receive sufficient practical training, and
o Has a minimum of 2 years of licensure in the province of Manitoba.
11
 Council may, from time to time, set other criteria for selection of preceptor pharmacists
and preceptor pharmacies, as it deems appropriate.
 Immediate family including parents, children, spouses, aunts, uncles, grandparents,
grandchildren, siblings, and in-laws cannot serve as preceptors for family members.
Attendance
 Attendance at the pharmacy is mandatory.
 All internship hours must be completed according to the schedule arranged with the
preceptor.
 Interns are expected to work with their preceptors to facilitate the maximum exposure to
clinical experiences and patient contact, but may also work with other licenced pharmacists
or healthcare professionals.
Post-Graduation
 A postgraduate pharmacy intern, under a licensed pharmacist’s supervision, may engage in
any aspect of pharmacy practice, excluding practices requiring additional training and
certification by the College (unless the intern has received training as part of the
undergraduate program at the University of Manitoba, College of Pharmacy, and the
preceptor pharmacist (or another pharmacist at the practice site) has received
authorization from the College of Pharmacists of Manitoba to perform these roles). These
additional practices include administering drugs by injection and prescribing drugs for self-
limiting conditions.
 The postgraduate internship may include performing the final check of a prescription only
after successfully completing the demonstration of product release proficiency (DPRP)
activity, and if permitted by the preceptor. The preceptor must be satisfied that the intern
has sufficient knowledge, skills and judgements to perform a final check safely and
effectively. Even if the DPRP was successfully completed during the undergraduate portion
of the internship, the intern must wait until after graduation to independently perform the
final check. The DPRP check must be completed at the site the intern is planning to
conduct the final prescription check. Once the DPRP has been successfully completed, the
preceptor or another licensed pharmacist does not have to perform the final check if it has
been done by the postgraduate intern (as allowed by sections 70(1)(j) and 70 (1)(k) of the
Pharmaceutical Regulations). However, the preceptor would make this decision and bear
the responsibility.
Evaluation
 The assessment of the pharmacy intern shall be made by the preceptor on evaluation
forms provided by the Registrar.
o The assessment will be based upon evaluations completed after each third of the
internship, including a final evaluation when the internship period is finished (that is
12
every 120 hours for a 360 hour internship and every 200 hours for a 600 hour
internship).
o The completed evaluation forms shall be returned to the Registrar within 7 days of
the completion of each 120/200 hour assessment section.
o The completed assessment forms shall be signed by both the intern and the
preceptor.
 An assessment of the preceptor and internship program shall be made by the intern on
evaluation forms provided in this Internship Manual.
o The completed assessment forms shall be returned to the Registrar by the pharmacy
intern within 7 days of the completion of the internship program.
 Successful completion of the internship program shall be based on a recommendation by
the preceptor through the assessment of the intern's performance throughout the
internship program.
o The preceptor must sign and date the “Statement of Completion” verifying that the
intern has successfully (or unsuccessfully) completed the internship. If the preceptor
is unsure if the candidate is successful, they can request the opinion of a second
preceptor.
o The “Statement of Completion” shall be returned to the Registrar by the preceptor
within 7 days of the completion of the internship program.
Unsuccessful Completion
 If the intern is not recommended for registration and licensure by the preceptor, the intern
will not be eligible for registration as a pharmacist under the Manitoba Pharmaceutical Act.
The opinion of a second preceptor, assigned by the College, can be obtained. If after a
second preceptor has deemed the applicant unsuccessful, the intern may appeal this
decision to Council within 30 days, as per the Pharmaceutical Act, Appeals Section 21(1).
This can be done by filing a notice of appeal in writing with the Registrar by confirmed
delivery (registered) mail.
13
Intern Responsibilities
As an intern, it is your responsibility to:
 Be aware and respectful of the time required to process your registration and
submission of relevant documentation to the College office before starting, during, and
after completion of your internship program.
 Provide the College with:
o A Criminal Record Check,
 Must be from the Royal Canadian Mounted Police or any other Canadian police service,
which confirms the check was completed using Canadian Police Information Centre (CPIC)
and/or based on the National Repository of Criminal Records (of Canada)
 A Child Abuse Registry Check under The Child and Family Services Act, and,
 An Adult Abuse Registry Check under The Adult Abuse Registry Act.
 Review this manual with your preceptor and give him/her a copy for reference. Identify
and agree on the objectives for your internship program.
 Be aware of, and adhere to all of the policies and procedures of your practice site.
 Exhibit a professional appearance in manner, attire, and attitude. Interns are expected
to follow the site’s dress code.
 Be punctual.
 Be motivated, self-directed, and assume responsibility for your own learning.
 Approach your internship training with a commitment to actively participate in all
learning experiences.
 Develop lifelong learning skills, including: self-assessment, self-directed learning and
reflection on learning.
 Identify yourself as an intern; do not represent yourself as a pharmacist.
 Keep all practice site policies, operations, records and patient information strictly
confidential. If you are asked to sign a Confidentiality Agreement, be sure to carefully
read and understand what you are signing. Ask questions if you are unsure.
 Safely practice within the boundaries of your knowledge, skills, and abilities.
 Acquire knowledge and develop new skills by observing, asking questions, researching
information, being open-minded, and willing to cooperate.
 Perform a variety of tasks and activities to apply your acquired knowledge and skills in
practice situations under the direct supervision of your preceptor.
 Maintain a daily personal log of activities performed. Use this log to recall competencies
demonstrated while filling out the Evaluation Forms with your preceptor.
Intern Responsibilities 14
 Receive approval or advice from your preceptor or another pharmacist before
implementing professional decisions or judgments.
 Do not publicly question the advice, direction or criticism of your preceptor, or other
pharmacist, but discuss any concerns in private.
 Seek regular consultation with your preceptor or other pharmacists to obtain feedback
on your performance.
 Seek help when you are unsure of what you should do.
 Evaluate your experience fairly and objectively, offering constructive feedback to your
preceptor.
 Be familiar with and apply the principles of Failure Modes and Effects Analysis (FMEA) in
order to prevent errors and improve safety.
 Be familiar with the goals of the internship program and bring course materials to the
site each day.
 Immediately notify the College office if you discontinue your training program.
 Discuss any issues or barriers to learning with the supervisor and the College in a
timeframe that allows for supportive action to be taken.
 Comply with applicable federal and provincial legislation and the Pharmaceutical Act,
By-laws, Regulations, Code of Ethics, Standards of Practice and Practice Directions of the
College which govern the profession of pharmacy. Particular attention should be paid to
the following (which can be found on the Legislation and Supporting Documents page of
the College Website, www.cphm.ca):
 Guide to Pharmacy Practice in Manitoba
 Code of Ethics and related descriptors
 Standards of Practice and Practice Directions (see section 56 of the Regulations)
 Personal Health Information Act (PHIA) and Regulations
 National Drug Schedules (see NAPRA website at www.napra.ca)
 Prescribing Practices: Doctor/Pharmacist Relationship
 Manitoba Prescribing Practices Program (M3P)
 Practice Guidelines
 Health Canada Prescription Drug List
Intern Responsibilities 15
Preceptor Responsibilities
As a preceptor, it is your responsibility to:
 Become knowledgeable about the goals and objectives of the structured training
program of the intern for whom you are serving as preceptor.
 Provide a safe and secure workplace and train the intern regarding applicable safety
measures/aspects of the practice site.
 Establish a tailored learning plan (objectives) with the intern for the training period.
Take into consideration the intern’s academic background, previous experience in a
pharmacy and the learning experiences and resources available at your pharmacy site.
 Act as a role model in the development of the intern’s professional and ethical values
and attitudes.
 Encourage active participation and involve the intern in appropriate decision making
situations under supervision.
 Provide time to answer questions or discuss concerns with the intern.
 Provide instruction and demonstrate desired skills to the intern before they undertake
new tasks or activities.
 Make the intern feel welcome by including him or her in informal discussions and any
pharmacy continuing education opportunities.
 Encourage critical thinking and problem solving by frequently posing problems to the
intern and asking him or her to formulate answers or responses.
 Supervise the intern and provide constructive feedback to assist in the further
development of his or her skills and competencies.
 Review the intern’s progress and revise the learning plan accordingly. Discuss the
intern’s accomplishments and any areas that need improvement. Suggest additional
activities to strengthen areas of weakness and improve the intern’s performance.
 At the end of the training period, constructively review the intern’s training plan with
him or her and provide feedback in a tactful, supportive manner. Collect feedback from
other pharmacists who may have worked with the intern to point out areas of strength
and possible opportunities for improvement of the intern’s skills, abilities and
knowledge.
 Consider the role of preceptor as a learning experience and be open to new ideas and
suggestions.
 Discuss questions of criticisms or disagreements in private.
 Seek feedback from the intern in order to assess your contributions as a preceptor.
 Evaluate the training program fairly and objectively, offering constructive feedback.
 Evaluate the patient care, professional and communication skills of the intern.
Preceptor Responsibilities 16
 Be familiar with and apply the principles of Failure Modes and Effects Analysis (FMEA) in
order to prevent errors and improve safety.
 Notify the College office if the intern withdraws, or ceases training at your site.
 Review the following activities and information with the intern:
o Orientation to the pharmacy including dispensary layout, hours of operation,
services offered, drug information resources, dress code, confidentiality, third
party billing, staff introductions, roles and functions, store policies and
procedures, etc.
o Role and functions of the following associations:
 College of Pharmacists of Manitoba (The College)
 Pharmacists Manitoba (PM)
 Canadian Pharmacists Association (CPhA)
 Canadian Society of Hospital Pharmacists (CSHP)
 National Association of Pharmacy Regulatory Authorities (NAPRA)
o Food & Drugs Act, Controlled Drugs and Substances Act, PHIA, the
Pharmaceutical Act, By-laws, Code of Ethics and descriptors with the intern
(available at www.cphm.ca)
o Review and be knowledgeable of the new Regulations and relevant Standards of
Practice and Practice Directions. Understand the new practice roles of pharmacists
under the legislation by reviewing the Guide to Pharmacy Practice in Manitoba
(available at www.cphm.ca).
o Contents of the College webpage, examining each section and the documents
contained therein.
 Complete all applicable forms and evaluations.
 Ensure that any intern engaged in practice has the level of supervision that, in the
professional judgement of the preceptor, is required to ensure safe and effective
patient care given the knowledge, skills, and experience of the pharmacy intern.
Preceptor Responsibilities 17
The College of Pharmacists of Manitoba
The pharmacy regulatory and licensing authority in Manitoba was established in 1878 and was
known as the Manitoba Pharmaceutical Association (MPhA). On January 1, 2014, the new
Pharmaceutical Act and regulations came into effect and MPhA became the College of
Pharmacists of Manitoba (College). The principal mandate of the College is protection of the
public. The vision, mission and values of the College of Pharmacists of Manitoba are as follows:
Vision
Leader in patient safety by creating the framework for collaborative and innovative
patient-centred pharmacy practice.
Mission
To protect the health and well-being of the public by ensuring and promoting safe,
patient-centred and progressive pharmacy practice in collaboration with other health-
care providers.
Values
The College activities are based on the following values and are the foundation of what
we do:
 Integrity: We act with professional and honest conduct.
 Respect: We are considerate of the values and needs of others.
 Excellence: We strive to attain high quality and exemplary performance.
 Accountability: We are responsible for our actions in an open and transparent
manner.
 Collaboration: We strive to include teamwork and partnership.
 Life Long Learning: We continue to enhance our knowledge and competency.
Rules Governing Practice
The intern must be familiar with the provisions of the Manitoba Pharmaceutical Act, the
Regulations thereto, and all other applicable federal and provincial Acts. In reviewing this
legislation, particular attention should be given to the following:
 New practice roles under the December 2006 Pharmaceutical Act (Bill 41)
 Purposes
 Membership
o Types of registration (pharmacists, extended practice pharmacists, conditional and
temporary registrants, students, interns and academic registrants)
 Pharmacy Licenses
o Categories of licenses (community, hospital and clinical practice)
o Components of community and hospital pharmacy licenses
 Meetings (annual and special)
The College of Pharmacists of Manitoba 18

 Inspections conducted by the College
 Council (see by-laws)
 Code of Ethics and descriptors
 Standards of Practice (see section 56 of Regulation and the Standards of Practice
documents)
 Practice Directions
 Drug Program Information Network (DPIN)
 Continuing Competency
 Personal Health Information Act (PHIA)
 National Drug Schedules see NAPRA website at www.napra.ca
 Prescribing Practices: Doctor/Pharmacist Relationship
 Joint Statements
o Facsimile and Electronic Transmission of Prescriptions
 Manitoba Prescribing Practices Program (M3P) Questions & Answers and DPIN Entry
Documents
 Practice Guidelines
 Prescribing authority of pharmacists and other health professionals – nurse practitioners,
dentists, midwives, clinical and physician assistants and optometrists
 Medication error procedures
 Guide to Pharmacy Practice in Manitoba
The College of Pharmacists of Manitoba 19

Orientation to the Pharmacy
The following is a guideline for the intern's orientation to the pharmacy at the commencement of
his/her internship.
Community Pharmacy
Date
A. Tour of the pharmacy
completed:
1 Drug storage areas in the front store and compliance with drug schedules
2 Keys
3 Entrances and exits
4 Security devices
Dispensary:
 stock room
5
 equipment and supplies
 speciality areas
6 Counselling area
B. Introduction to employees and explanation of duties, responsibilities and lines of Date
authority completed:
1 Pharmacists
2 Pharmacy technicians and other persons (pharmacy assistants)
3 Front store personnel
4 Cashiers
5 Delivery personnel
6 Other staff
Date
C. Discussion of pertinent policies and procedures
completed:
1 Dress code
2 Schedule and tracking of intern hours
3 Refunds policy
4 Telephone procedures and answering machine
5 Customer relations
Confidentiality, Personal Health Information Act (PHIA) and Personal Information
6
Protection and Electronics Document Act (PIPEDA)
7 Handling of medication errors
8 Delivery
9 Pharmacy opening and closing
10 Staff purchases
11 Discounts to professionals
12 Shoplifting, armed robbery, security
13 Handling of damaged stock
Lock and Leave (if applicable)
14
 Storage of drugs in the enclosure
Orientation to the Pharmacy 20

 Physical barrier separating the enclosure from the remainder of the
premises
 Hours of operation
 Exterior signage
15 PHIA documentation
16 Patient care documentation
Date
D. Dispensary layout
completed:
The intern should be made aware of all the physical necessities of the dispensary, where products and
equipment are located. The intern should be encouraged to ask questions as to the logic and necessity of
the physical workings of the dispensary. The preceptor should emphasize the following points:
Layout
1 Dispensing stations
Drugs (solid-dose, liquid dose, bulk supplies, ear, nose and throat, rectal and
2
vaginal, injectable, topical products)
3 Drug distribution system (e.g. company, alphabetical, automated, robotic)
4 Distilled/demineralized water
5 Library and reading area
6 Vials (childproof and plain), prescription labels, auxiliary labels
7 Equipment for weighing and measuring
8 Syringes and needles
9 Prescription files
10 Confidential area for patient counselling
11 Confidential area for prescribing or administering injections
12 Abuse-potential products sold from dispensary
13 Unauthorized access
14 Storage of prepared prescriptions
15 Distribution of prepared medication pursuant to the prescription
16 Patient information leaflets
17 Drugs under schedules II and III and their location in the pharmacy
Drug storage areas
1 Access and secure storage of narcotic & controlled drugs
2 Refrigerated products
3 Schedule II and III medications
4 Unscheduled products
Date
E. Third party claims
completed:
1 Manitoba Drug Benefits and Interchangeability Formulary
2 Computer processed non-government third party insurance claim procedures
3 Computer processed government third party claim procedures
Other third party claim procedures (Workers Compensation, Autopac, non-
4
computer processed insurance cards)
5 DPIN Procedures

6 Prescriber identification
7 Compulsory (MY and MZ) response codes
8 Prescription reversals (online/manual)
Pharmacare program issues such as vacation supply and coverage under
9
Exception Drug Status (part II and III).
Date
F. Library & reference
completed:
The intern should be made aware of the library facilities in the dispensary with emphasis on:
1 CPS (use and correlation of the various sections)
2 Internet access (including use of email)
3 Patient counselling resources
4 Drug interaction and toxicology resources
5 Drug product catalogues
6 Dosage information (e.g. pediatric)
7 New drug information systems
8 Access to the College legislation, regulations and practice directions
9 The pharmacy’s Policy and Procedure Manual
NAPRA drug schedules with specific references to Schedule II and III and products
12
contained therein
Date
G. Other pharmacy areas
completed:
The preceptor should make the intern aware of other areas of the pharmacy outside the dispensary
including (if applicable):
1 Self-medication products
2 Diabetic supplies
3 Home care supplies and devices
4 Patient information area
5 Self-testing products (blood glucose and BP monitors)
6 Administration of injections

Hospital Pharmacy
Date
A. Tour of the pharmacy
completed:
1 Drug storage areas in pharmacy and institution
2 Outpatient services
3 Entrances and exits
4 Security devices
5 Dispensary/counselling area
6 Stock room
7 Equipment and supplies
8 Specialty areas
B. Introduction to employees and explanation of duties, responsibilities and lines of Date
authority completed:
1 Pharmacists
2 Pharmacy technicians and other persons (pharmacy assistants)
3 Support staff
4 Other healthcare professionals
Date
C. Discussion of pertinent policies and procedures
completed:
1 Dress Code
2 Schedule and tracking of intern hours
3 Telephone procedures
4 Confidentiality and PHIA
5 Patient unit of use/unit dose
6 Pharmacy opening and closing
7 Handling of medication errors
8 Handling of damaged and expired stock
9 Pharmacy security, armed robbery
Date
D. Dispensary layout
completed:
The intern should be educated on the locations of drug products and equipment within the dispensary.
The intern should be encouraged to ask questions as to the logic and necessity of the physical workings of
the dispensary. The preceptor should emphasize the following points:
Layout
1 Dispensing stations
Drugs (solid-dose, liquid dose, bulk supplies, ear, nose and throat, rectal and
2
vaginal, injectable, topical products)
3 Drug distribution system (e.g. company, alphabetical, automated, robotic)
4 Distilled/demineralized water
5 Library and reading area
6 Vials (childproof and plain), prescription labels, auxiliary labels
7 Equipment for weighing and measuring

8 Syringes and needles
9 Prescription files
10 Controlled and narcotic drug storage
11 Confidential area for patient counselling
12 Dispensary-only sale products
13 Abuse potential products dispensed from dispensary
14 Unauthorized access
15 Storage of prepared prescriptions
16 Distribution of prepared prescriptions
17 Patient information services
Drug storage areas
1 Access and storage of narcotics and controlled drugs
2 Refrigerated products
3 Sterile products
4 Investigational/emergency drugs
5 Ward stock storage, Pyxis
6 Expired stock
Date
E. Library & reference
completed:
The intern should be made aware of the library facilities in the dispensary with emphasis on the
following:
1 CPS (use and correlation of the various sections)
2 Internet access (including the use of email )
3 Patient counselling resources
4 Drug interaction and toxicology resources
5 Drug product catalogues
6 Dosage information (e.g. pediatric)
7 New drug information systems
8 Access to the College legislation, regulations and practice directions
9 The pharmacy’s Policy and Procedure Manual
10 PHIA documentation
11 Patient care documentation
12 Parenteral drug manual
13 Compounding Formulas

Professional Competencies
for Canadian Pharmacists at Entry to Practice
Professional Competencies for Canadian Pharmacists at Entry to Practice 25

1. Ethical, Legal and Professional Responsibilities
Pharmacists practice within legal requirements, demonstrate professionalism and uphold
professional standards of practice, codes of ethics and policies.
Key Competencies
Pharmacists are able to:
1.1 Practise within legal requirements.
1.2 Uphold ethical principles.
1.3 Manage actual and potential illegal, unethical, or unprofessional actions or
situations in practice.
1.4 Apply principles of professionalism.
1.5 Document activities of practice in compliance with federal and provincial/territorial
legislation, standards and policies.
A number of daily interactions in the pharmacy call for professionalism and tact, including:
patients wanting to change or return their medication, patients refusing medication because they
can't afford it, a dispensing error, or a prescription which the pharmacist is unable to fill/refill. In
any situation, pharmacists must always uphold ethical principles and act professionally.
Patients may confide in a pharmacist either on their own initiative, or after a visit with another
health care provider. Any information (verbal or on the patient’s medication record) regarding
their illness, treatment, or prescribed medication MUST be kept confidential. Aside from
prescriptions, purchases made in the pharmacy of a personal nature should also be handled as
discreetly as possible. All conversations with the patient that include personal health information
must occur in a manner that protects the patient’s right to privacy and confidentiality. All
procedures must be in compliance with the Personal Health Information Act (PHIA).
Code of Ethics
The Code of Ethics is set forth in Section 76 of the Pharmaceutical Act and has been approved by
the members of the College. The Code of Ethics governs the conduct of members, students,
interns and owners. The practice of pharmacy is a profession dedicated to the service of public
health; the well-being of the patient should always be the pharmacist’s primary concern.
Pharmacists are expected to uphold professional conduct in all areas of their practice. It is the duty
of the profession to promote and enforce such rules of conduct that will best serve the interests of
the public and the profession, and will enhance public esteem of the profession.
Statement I Pharmacists shall maintain a high standard of professional competence

throughout their practice.
Statement II Pharmacists shall cooperate with colleagues and other healthcare

professionals to ensure optimal patient-centered care.
Statement III Pharmacists shall contribute to societal health needs and promote justice in
Ethical, Legal and Professional Responsibilities 26

the distribution of health resources.
Statement IV Pharmacists shall respect and protect the patient’s right of confidentiality.
Statement V Pharmacists shall respect the autonomy, values and dignity of each patient.
Statement VI Pharmacists shall respect and maintain a professional relationship with each
patient.
Statement VII Pharmacists shall hold the health and safety of each patient to be of primary
consideration.
Statement VIII Pharmacists shall act with honesty and integrity.
Statement IX Pharmacists shall respect the rights of patients to receive healthcare.
Statement X Pharmacists shall respect and honour the profession of pharmacy.
Note: Please review the College’s explanatory document, Applying the Code of Ethics in Pharmacy
Practice. This document further describes the obligations of pharmacists in upholding legal and
ethical pharmacy practice.
Pharmacists’ refusal to fill and obligation to provide patient care
According to the Standards of Practice (Section 1.9):

Pharmacists shall hold the health and safety of the public to be their first consideration in the
practice of their profession. Pharmacists who object, as a matter of conscience, to providing a
particular pharmacy product or service must be prepared to explain the basis of their
objections. Objecting pharmacists have a responsibility to participate in a system designed to
respect a patient’s right to receive pharmacy products and services.
The intern and preceptor should discuss this caveat and how this would be managed in the
pharmacy.
Ethical, Legal and Professional Responsibilities 27

2. Patient Care
Pharmacists, in partnership with the patient and in collaboration with other health
professionals, meet the patient’s health and drug-related needs to achieve the patient’s health
goals.
Key Competencies
2.1 Develop a professional relationship with the patient.
2.2 Obtain information about the patient.
2.3 Assess the patient’s health status and concerns.
2.4 Determine the patient’s actual and potential drug therapy problems.
2.5 Develop the patient’s care plan, in partnership with the patient and in collaboration
with other health professionals.
2.6 Implement the patient’s care plan.
2.7 Administer drugs to the patient using the necessary technical skills and applying the
appropriate clinical knowledge.
2.8 Monitor the patient’s progress and assess therapeutic outcomes.
Pharmacists often have contact with patients who are ill and suffering. Empathy shows the patient
you understand what they are experiencing. Effective healthcare means more than technical
support: feelings of security and well-being must also be considered and understood.
The pharmacist’s role is progressing from supplying drug products to using his or her professional
knowledge, skills and experience to identify, prevent and resolve drug therapy problems.
Pharmaceutical care is defined as “the responsible provision of drug therapy for the purpose of
achieving definite outcomes that improve the patient’s quality of life.” To move to pharmaceutical
care, three important philosophical changes are necessary:
1. Focus on the patient, rather than on the drug(s) or disease(s)

2. Take responsibility for your patient’s drug therapy
3. Work with the patient to achieve a desired outcome
Overview of the Pharmaceutical Care Process
 Establish a professional relationship with the patient and make a commitment to the
patient.
 Collect and interpret relevant information about the patient, his or her relevant medical
history and current and past medication history.
 List and rank all of the patient’s actual and/or potential drug therapy problems.
 With the patient, establish desired therapeutic outcomes for all drug therapy problems.
 Determine all the therapeutic alternatives that could achieve the desired outcome.
 With the patient, choose the “best” therapeutic solution and individualize the regimen
(best drug, dose, formulation, regimen, schedule, etc.)
Patient Care 28
 Design a drug-monitoring plan that determines whether the desired outcome has been
achieved and monitor for adverse effects.
 With the patient and physician, implement the individualized regimen and monitoring
plan. Don’t forget to document your plan.
 Follow up with the patient to ensure that the desired outcome is achieved.
Pharmaceutical Care Plan
The purpose of developing a pharmaceutical care plan is to ensure that all drug therapy problems
have been resolved. Generally, there are three components to a care plan:
1) With the patient, determine a desirable outcome for the drug therapy problem. There are
four possible outcomes:
i) Cure a disease
ii) Prevent a disease or disease symptoms
iii) Stop or slow down a disease process
iv) Reduce or eliminate symptoms
A problem may have multiple outcomes (short-term, intermediate, and long-term
outcomes).
2) Develop and implement a therapeutic plan. The plan should outline the actions to be
taken in order to resolve the problem. In collaboration with the patient and practitioner,
therapeutic alternatives can be recommended that best suit the patient’s situation and
needs.
3) Develop and implement a monitoring plan that identifies the specific signs, symptoms or
measurements to monitor. Educate the patient on the time frame for the expected
changes and how often to monitor the changes. Goals should be measurable and made
with the patient. Follow-up with the patient to determine if the desired outcome has
been achieved.
Drug Therapy Problems
A drug therapy problem is defined as “an undesirable event experienced by a patient that involves,
or is suspected to involve, drug therapy, and that interferes with achieving the desired goals of
therapy and requires professional judgment to resolve.”
There are seven possible classifications of drug therapy problems:
1) The drug therapy is unnecessary because the patient does not have a clinical indication.
2) Additional therapy is required to treat or prevent a medical condition.
3) The drug product is not effective at producing the desired response in the patient.
4) The dosage is too low to produce the desired response in the patient.
5) The drug is causing an adverse reaction in the patient.
6) The dosage is too high, resulting in undesirable effects in the patient.
Patient Care 29
7) The patient is not able or willing to take the drug therapy as intended.
Implementing the Patient’s Care Plan
The pharmacist and other healthcare professionals are extremely busy members of the healthcare
team. The pharmacist can play a valuable role closing gaps in the healthcare system. The
additions to the Manitoba Pharmaceutical Regulation enable pharmacists to do just that. Ensure
the intern is familiar with these responsibilities.
 Prescribing - Pharmacists may only issue a prescription after conducting a patient

assessment, explaining all therapeutic alternatives, and giving the patient enough
information to make an informed decision. The practice direction, Prescribing and
Dispensing [Standard of Practice #4] further describes all necessary steps to issuing a
prescription.
 Administering Drugs - Pharmacists can be instrumental in providing the public with the
important information to make informed choices. Prior to administering a drug
(including vaccines), the pharmacist must complete an initial assessment of the patient.
Consent from the patient or the patient’s agent must be obtained prior to
administration. The practice direction, Administration of Drugs including Vaccines,
discusses all requirements for this patient service.
 Ordering Lab Tests - Currently, lab test ordering for outpatients has not been
implemented. Hospital pharmacists may already have limited ability to order lab tests
for inpatients of a hospital, depending upon the policy and lab access at the hospital.
When ordering a lab test listed in Schedule 1 to the Regulation, the pharmacist must
counsel the patient on: the clinical significance of the test, potential implications of the
results, the proper procedure for the test, and how the results will be communicated to
the patient. The prescriber must be informed of the lab test, the rationale, the results
and any recommendations in a prompt manner.
 Test Interpretation - The practice direction, Test Interpretation, outlines the guidelines
for this activity as well as documentation requirements. Once the pharmacist has
confirmed the test was performed correctly, the patient should be given an
interpretation of the results. The patient should also be informed of what actions need
to be taken by both the patient and the pharmacist, and whether or not the patient
should see their physician. Pharmacists can only interpret patient-administered
automated tests that are within their knowledge, skills and experience.
Patient Care 30
Drug Schedules
NAPRA has developed and published national drug schedules for pharmacists, corresponding to
the level of professional intervention and advice necessary for the safe and effective use of
drugs by the consumer. These documents were approved for use in Manitoba in 2006. The
latest listing of the drug schedules is available through the NAPRA website at www.napra.ca.
o Schedule I drugs require a prescription for sale and are provided to the public by the
pharmacist following the diagnosis and professional intervention of a practitioner. The
sale is controlled in a regulated environment as defined by provincial pharmacy
legislation.
o Schedule II drugs require professional intervention from the pharmacist at the point of
sale. While a prescription is not required, the drugs are available only from the
pharmacist and must be stored within an area of the pharmacy where there is no public
access and no opportunity for patient self-selection.
o Schedule III drugs may present risks to certain populations in self-selection. Although
available without a prescription, these drugs are to be sold from the self-selection area
of the pharmacy which is immediately adjacent to the dispensary. The pharmacist must
be available, accessible and approachable to assist the patient in making an appropriate
self-medication selection.
o Unscheduled drugs can be sold without professional supervision. Adequate information

is available for the patient to make a safe and effective choice and labelling is deemed
sufficient to ensure the appropriate use of the drug. These drugs are not included in
Schedules I, II or III and may be sold from any retail outlet.
Prescribing and Recommending Schedule II and III drugs and Medical Devices
Under the Regulation, a pharmacist may prescribe a Schedule II or III drug, a drug with a drug
identification number (DIN) or a natural health product number (NHP) not in the NAPRA
schedules, or a Health Canada approved medical device. If the patient required a prescription
for insurance purposes or if the product was to be included in the patient’s compliance
packaging, the pharmacist could prescribe the medication, rather than another prescriber. In
such cases, the pharmacist must comply with the regulations, standards of practice and all
applicable practice directions including Prescribing and Prescribing and Dispensing.
When a patient consults the pharmacist for a recommendation on a non-prescription product,

this is not considered prescribing. A pharmacist must ensure to take the following measures
when providing a recommendation for a patient:
 Use effective communication skills to obtain information from the patient regarding
symptoms (onset, duration, severity, frequency, and self-treatment history), other
medical problems, drug therapies, and allergies.
Patient Care 31
 Make professional judgments about the patient’s condition and the need for self-
medication or referral to a physician or other health professional.
 Critically evaluate non-prescription drug products and natural health products with
respect to composition, contraindications, effective dose and therapeutic action.
 Select an appropriate product(s) and counsel the patient on the proper use, dosage,
precautions and side effects of the medication.
 Obtain feedback regarding the patient’s understanding of the recommendations and

answer any questions that the patient may have.
 Encourage appropriate follow-up on the patient’s response to the non-prescription drug

products.
 When appropriate, document the interaction in the patient profile to assure continuity
of care.
 Identify the various regulations affecting the sale of non-prescription drug products and
natural health products and their implications.
Patient Care 32
3. Product Distribution
Pharmacists ensure accurate product distribution that is safe and appropriate for the patient.
Key Competencies
3.1 Dispense a product safely and accurately that is appropriate for the patient.
The dispensing procedure could appear relatively simple. What is not immediately apparent are
the dozens of decisions made by the pharmacist during the process.
The preceptor must impress upon the intern that the dispensed medication must be correct, safe
and effective when released to the patient, and that the pharmacist alone bears responsibility for
the accuracy of the finished prescription. The patient is vulnerable in this situation, and accurate
dispensing is fundamental to all the other valuable professional services the pharmacist is
expected to provide. Some pharmacists develop a dispensing checklist and with each prescription,
use the list to consciously check off each step to ensure that the prescription is filled accurately
and efficiently. Using this checklist helps ingrain the dispensing thought process. Another useful
resource is the practice direction developed by the College, see the Drug Distribution Practice
Direction on the website for further information.
The dispensing procedure could be expressed in a series of steps and contain multiple procedures
as follows:
1. Checking for completeness of information

 Prescription must be recent and all statutory information present.
 Obtain patient's age, weight, allergies and type of reaction, any self-medication, dietary
restrictions, prior and present medical problems, and enter in the patient’s record.
 Ascertain method of delivery to patient (waiting, call later, delivery, given to patient's
agent) and give estimated waiting time.
 Determine any third-party coverage and subscriber's number.
 Determine what to do if the order is not legally complete.
 The preceptor should impress upon the intern the fact that the onus is upon the
pharmacist to determine if a prescription is legitimate, appropriate and valid.
2. Checking the prescriber information

 Is the prescriber licensed to practice in a province in Canada?
 In hospital practice, is the prescriber a resident? Intern? Does he/she have prescribing
privileges?
 Is the prescription within their scope of practice?
 What if the prescriber recently moved from the province or is now deceased?
Product Distribution 33
3. Interpreting the prescription
 Be aware of look-alike and sound-alike drugs.
 Leave of Absence (LOA) or “pass” medications (hospital).
 Interpret handwriting and abbreviations, and understand the prescriber’s intent.
 Be capable of recognizing errors or omissions and know what action to take.
 Check for safe and appropriate dosage (referring to appropriate resources as required)
and mode of administration.
 Be prepared to communicate with the prescriber and/or patient.
4. Check patient records

 Contraindications (allergy, disease state or medication) and any other factors affecting
drug use/abuse.
 Patient medication history.
 Drug Program Information Network (DPIN) and importance of drug duplication and
drug interaction codes.
 Exception Drug Status (EDS) response codes.
 Mandatory code responses and documentation.
 What other codes are important?
 When critical patient care codes appear from DPIN (MY - duplicate drug, other
pharmacy; MZ - duplicate therapy, other pharmacy), either separately or in addition to
other codes, the pharmacist must intervene and document the interventions on DPIN.
5. Adaptation of prescriptions
A prescription may be adapted by the pharmacist, but is limited to: dosage strength, dosage
interval, and/or the formulation. The pharmacist must have knowledge of the patient, the
condition being treated and the drug therapy.
The pharmacist may adapt the prescription if:

 The product is not commercially available or temporarily unavailable,
 If information is missing from the prescription and information can be obtained from
the patient, the patient’s record or other sources,
 Adaptation will facilitate patient adherence, or
 Adaptation enables the patient to benefit from approved or existing third party
coverage.
The pharmacist must follow the guidelines set out in the Practice Direction, Adaptation of a
Prescription, including informing the prescriber of the adaptation and the rationale. Also refer to
the Practice Aid: Adaptation.
6. Compounding
 Review Health Canada’s Policy on Manufacturing and Compounding Drug Products in
Canada (POL-0051).
 NAPRA’s Model Standards for Pharmacy Compounding of Non-Hazardous Sterile
Preparations
 NAPRA’s Model Standards for Pharmacy Compounding of Hazardous Sterile
Preparation
 NAPRA’s Model Standards for Pharmacy Compounding of Non-Sterile Preparations
7. Selecting container and labelling the product

 Select the appropriate container, bearing in mind the requirements in the Regulations,
physiochemical properties of the medication, the convenience to the patient and the
aesthetic appearance of the finished product.
 Selection of all appropriate auxiliary labels including storage and stability of the
medication.
 Prescription medication container must be labelled with the generic name for all single
entity products and with the trade name for multi-ingredient products.
 Review compliance packaging standards in the practice direction Drug Distribution .
8. Selecting the medication and transferring to container

 Select correct drug product from pharmacy's inventory (compare DIN of the inventory
container with the DIN on the prescription label).
 Ensure the drug has not expired or deteriorated.
 Know what to do when a drug is not stocked or there is not enough of the drug to
completely fill a prescription order.
 Note product name, manufacturer, strength, dosage form and quantity dispensed on
the prescription order and patient's medication record.
 Know the regulations of the Manitoba Drug Benefits and Interchangeability Formulary
and the effects of substitution legislation on the dispensing procedure (for hospital
practice, know the issues around formulary and non-formulary drugs).
 Know the proper procedure for "Do Not Substitute" prescriptions.
 Check finished dispensed medication for accuracy.
 Return the stock bottle to the dispensary shelf and note if it needs to be re-ordered.
 Be aware of cross contamination of products being counted in machines or on trays
leading to problems with allergies for the patients.
 Be aware of hazardous medications and the safe handling procedures for dispensing
these medications.
9. Permission for substitution
 Prescriptions will be received for medication that is urgently needed but not carried in
stock, not listed in the formulary, or not readily available from other sources.
 The prescribing health care professional must be contacted and permission sought for
an alternative. The practitioner will often enquire as to what similar medication is
available, and therefore alternatives should always be checked before the call is made.
 The substitution must be recorded on the prescription and the change signed by the
pharmacist. The prescriber’s authorization of the change must also be documented.
 Interchangeable Products: The preceptor and intern should review Part 9 of the
Pharmaceutical Act, Interchangeable Pharmaceutical Products. Discuss the impact “no
substitution” requests have on the dispensing process as well as interchangeable drug
pricing when the lowest priced drug is not available.
10. Pricing the prescription and third party payers

 Price the prescription (if applicable) taking into account store policy, lowest cost
alternatives, and deductible fee payable by patient.
 Complete third party computer claim information, manual claim forms or detailed
receipts for the patient to submit.
 Supply receipts for tax purposes.
 Be knowledgeable of vacation supply under the Pharmacare reimbursement plan.
11. Releasing the medication to the patient

 Review and comply with the practice direction Patient Counselling.
 Explain applicable quantity restrictions on third party prescriptions.
 Ask open-ended questions to assess the patient’s knowledge of their medication and
provide an opportunity to ask questions about the medication.
12. Cancelling dispensed medication that was not picked up by the patient
 Return medication to stock after integrity of medication is confirmed.
 Lot number, expiration date and stability of medication must be known.
 Reverse prescription as soon as possible in the DPIN system (as per Manitoba Health it
must be within 30 days).
13. Refilling a prescription

 Exercise professional judgement as to the content of dialogue on repeat prescriptions.
 Be able to recognize appropriate refill and part fill instructions (i.e. narcotics).
 Understand acceptable refill records (hard copy, logs, etc.).
 Know what steps to take to obtain authorization to renew a prescription, including
procedures for prescribers who will not accept verbal or fax renewal requests from a
pharmacy.
 Check for over- and under-utilization and know how to handle either situation.
 Know how to record refill information on the prescription order and the patient's
record.
 Know how to obtain a copy of a prescription from another pharmacy, obtain
authorization from a prescriber and fill it as a new order.
 Know how to transfer a prescription to another pharmacy.
 Know how to provide a Continued Care Prescription.
 Know how to handle patient needs for medications that are not eligible for a
Continued Care Prescription.
14. Medication errors

 Be familiar with the Incidents and Discrepancies practice direction.
 Know the pharmacy’s policy on reporting medication discrepancies or near misses.
 Be familiar with the pharmacy’s continuous quality improvement program.
15. Stale dating of prescriptions

Section 52(c) of the Benzodiazepines and Other Targeted Substances Regulations to the
Controlled Drugs and Substances Act states that a pharmacist may only refill a prescription for
a targeted substance if less than one year has elapsed since the day on which the prescription
was issued by the practitioner.
The one year expiry date placed on all non-targeted and controlled prescriptions is usually a
corporate policy or third party contract that prevents the pharmacy computer system from
automatically processing the refill. This limitation does not override the pharmacist’s
professional judgment to fill or not to fill a prescription. The pharmacist must use his/her
professional judgment in determining the validity of a prescription or refill. A review of the
patient’s medication profile, DPIN profile, and a discussion with the patient will help provide
additional information to verify if the medication therapy is appropriate, the patient is
adherent to the regimen, the refill dose is up to date, and the medication therapy is being
monitored by his/her current physician. The pharmacist must also consider the medical
condition for which the medication is prescribed when deciding to fill or refill the prescription.
16. Prescription returns
The Regulation to the Pharmaceutical Act (Section 85) state that no prescription or part
thereof may be returned to inventory for reuse. This is based solely on the grounds of possible
health hazards. Methods of appropriate drug disposal should be discussed with the preceptor.
Information regarding the Manitoba Medication Returns Program can be found on the College
website, or at: http://www.healthsteward.ca/returns/manitoba.
17. Prescription Transfers

The patient's prescription is his/her property and they are entitled to a copy of it if requested.
The information required on the prescription record is listed in section 70(1) of the Regulation
to the Pharmaceutical Act. As well, the proper procedure for receiving and providing
prescription transfers should be reviewed (Section C.01.041.1-C.01.041.3 of the Food and
Drugs Act Regulations). The approved standards for these practice directives should be
reviewed on the College website : Transfer of Patient care [Standard of Practice #10] and
Prescription Copies: Pharmacist Obligations and Considerations.
4. Practice Setting
Pharmacists oversee the practice setting with the goal of ensuring safe, effective and efficient
patient care.
Key Competencies
4.1 Optimize the safety, efficacy and efficiency of operations in the practice setting.
4.2 Oversee pharmacy inventory to ensure safe, effective and efficient patient care.
4.3 Oversee record keeping activities to ensure safe, effective and efficient patient care.
Pharmacy Operations
Community Pharmacy Management

Date
The following subjects should be discussed with the intern:
completed:
Security procedures, opening and closing, loss prevention, procedures to follow in the
event of armed robbery, location of alarm buttons, power failure policies, fire protection,
computer(s) back up policy, lock and leave procedures (if applicable).
Control of cash receipts, banking, change procurement, cheque and credit card policies.
Inventory control (both manual and computerized techniques). Criteria for decision
making when purchasing stock. Records kept with respect to the Narcotic and Controlled
Drug Accountability Policy approved by Council.
Advertising and promotion policies as they relate to wholesale advertising groups,
franchise organizations, corporate stores.
In Store: Special displays, shelf position, general merchandising considerations.
Media: Flyers or Newspaper advertising, Radio, TV, Bus Benches, etc.
Receiving, ordering and returns.
Speaking with manufacturer representatives and sales agents.
(Note: These representatives can provide useful information on the latest products and medications
available; however, they should not be allowed into the dispensary.)
Personnel management: Hiring practices, job descriptions, pharmacist-to-staff ratio,

performance evaluations, staff benefits, etc.
Pharmacy Technician Final Check policy and procedures (if applicable).
PHIA procedures (for new employees, existing employees, trustees, and other staff that
may occasionally enter the dispensary).
Practice Setting 39
Hospital Pharmacy Management
Date
The following subjects should be discussed with the intern:
completed:
Role played by the Department of Pharmacy in the provision of healthcare services in the
hospital.
Position of the department in the organizational chart of the institution.
Role and responsibility of the governing Regional Health Authority.
Satellite and decentralized service.
Functions of the Pharmacy and Therapeutics Committee.
Purpose of the hospital formulary.
Procedure for handling non-formulary requests.
Therapeutic substitutions.
Manitoba Institute for Patient Safety program for writing prescription orders.
Policy and Procedures Manual for the Department of Pharmacy.
Concept of quality assurance and the quality assurance program of the department.
Understanding of the basic differences among drug distribution systems (e.g. traditional,
total ward stock, unit-dose, centralized, decentralized, mobile, automated dispensing
systems, etc.)
Knowledge of drug distribution process from the time the order is written until the
medication is administered to the patient and charged to the cost centre.
Alternate Verification Program, if applicable.
Pharmacy Technician Final Check policy and procedures, if applicable.
Rationale for ward stock drugs.
Process for addition/deletion to ward stock.
Ward stock check.
Role and responsibility of pharmacy technicians under the distribution system.
Medication Reconciliation Program.
Knowledge of the purpose of Workload Measurement and the application of information
obtained.
Introduction to principles of personnel management such as department policy and
procedures, communication, supervision of employees and personnel evaluation.
Process involved with hospital accreditation.
Collaboration and patient care teams.
Procedures related to Hospital Incident Command System (HICS).
Practice Setting 40
Response to hazardous spills.
Sterile Products (knowledge of established policies and procedures, required product
research and calculations, aseptic technique, record-keeping procedures, disposal, Home
IV Program, etc.)
Patient Record and Retention
Each pharmacy will have a different patient record system, but they will all have the same
purpose (i.e. presentation and preservation of the overall drug history and a record of patient
care). The original prescription becomes a part of the prescription record which must be
retained for 5 years from the last date of the last refill. A record of care includes documentation
of the expanded pharmacy services including:
 Drug therapy problem(s) and the action taken or monitoring plans created to correct the
problem(s),
 Prescriptions adapted,
 Drugs prescribed,
 Drugs administered by injections,
 Lab tests ordered, and
 Other information such as prescriptions not filled and summaries of consultations with
other healthcare providers.
According to the Regulations, the retention period is also 5 years from last activity on the
patient record for the following records:
 Prescription record;
 Patient profile;
 Counseling record;
 Drug acquisition and sales;
 Prescriptions or copies of them, if they were refused to be filled;
 Drug administration record;
 Test interpretation record;
 Test ordering and results record; and
 Prescribing record.
The pharmacist is responsible for the interpretation of the information in the records. The
ongoing monitoring of each patient’s drug therapy interventions should be documented. These
records can be recorded and retained either electronically or in written form. However if a
signature or initial is required on the record then it must be an original or electronic signature
or initial.
Practice Setting 41
5. Health Promotion
Pharmacists use their expertise to advance the health and wellness of patients, communities
and populations.
Key Competencies
5.1 Engage in health promotion activities with the patient.
5.2 Participate in public health activities.
5.3 Contribute to the maintenance of a healthy environment for the public.
Since pharmacists are the most accessible healthcare providers, they have many opportunities
to use their new practice roles to promote the health and well-being of their community.
Pharmacists will often make referrals to appropriate community resources when it is necessary.
The intern should be familiar with local services in their pharmacy area such as:
 Local physicians and dentists who will accept new patients

 Walk-in clinics
 Nearest emergency services (hospital, cardiac resuscitation, ambulance, etc.)
 Local poison control centre phone number, Manitoba Poison Centre (toll-free): 1-855-
776-4766 (1-855-7POISON)
 Where a patient can find financial assistance with medication costs
 Manitoba Health Pharmacare inquiries: 1-800-297-8099
 Manitoba Addictions (AFM) Helpline: 1-855-662-6605
 Canadian Mental Health Association Klinic Crisis line: 1-888-322-3019
They should also be actively involved in public health activities, such as provincial immunization
programs.
Health Promotion 42
6. Knowledge and Research Application
Pharmacists access, retrieve, critically analyse and apply relevant information to make
evidence-informed decisions within their practice with the goal of ensuring safe and effective
patient care.
Key Competencies
6.1 Apply knowledge, research skills and professional judgment to the decision-making
process.
6.2 Respond to questions using appropriate strategies.
6.3 Apply relevant information to practice.
Pharmacists, regardless of the role they are fulfilling, must recognize and practice within the
limits of their competence. They must use evidence from relevant sources to inform their
activities and critically evaluate medication and related information. When providing
information to patients they must present medication and related information in a manner
appropriate to the audience. Pharmacists must also adhere to current laws, regulations and
policies applicable to pharmacy practice. The intern should be familiar with the sources of
information both within the pharmacy and from outside sources.
Knowledge and Research Application 43

7. Communication and Education
Key Competencies
7.1 Establish and maintain effective communication skills.
7.2 Implement safe, effective, and consistent communication systems.
7.3 Deliver an education session to an individual or group.
The communication skills taught in University can be enhanced through practical pharmacy
experience. This is a critical component of internship. The intern can be exposed to this by listening
closely to a pharmacist who is already experienced in explaining care concerns to the patient. The
importance of open ended questioning, using lay language, and being empathetic should be
stressed.
Communicating with people in the busy surroundings of most pharmacies is much easier if the
pharmacy staff know their patients and the patients know the staff by name. The intern should be
wearing a visible nametag. Encourage the intern to get out of the dispensary and meet patients.
Mandatory Patient Counselling
Pharmacists should be aware that patient counselling is mandatory on all prescriptions in

Manitoba. The following information must be relayed to the patient each time a drug is dispensed
for the first time (on refills, the information can be adjusted to meet the needs of the patient):
a) Confirm the identity of the patient
b) Name and strength of the drug being dispensed
c) Purpose of the drug
d) Directions for use, including the frequency, duration and route of therapy
e) Importance of adherence and what to do if a dose is missed
f) Significant drug-drug (including non-prescription medication) and drug-food
interactions
g) Activities to avoid
h) Common side effects and what to do if they occur
i) Special storage requirements
j) Prescription refill information
Communication and Education 44

k) How to monitor response to therapy
l) Expected therapeutic outcomes
m) When to seek medical attention
n) Any other information unique to the specific drug or patient.
Counselling must take place in an area which allows for a confidential conversation. In hospital
practice, the above information should be included in all patient conversations about medication
and medication use. The pharmacy department, in cooperation with the medical and nursing
staff, may develop policies and procedures regarding patient self-medication, patient
counselling and drug history programs that would be subsequently approved by the Pharmacy
and Therapeutics Committee and Administration.
Non-Prescription Medication Counselling
Effective non-prescription drug counselling requires a thorough understanding of the patient's

symptoms. Before advice can be given, the intern must obtain information on the nature, severity
and extenuating circumstances surrounding those symptoms. As well, other aspects of the
patient's health (e.g. other diseases, drugs, contraindications, allergies) must be examined. This
information-gathering stage is very important.
When non-prescription drugs are indicated, the intern must be able to give information to the
patient so products are used both safely and effectively.
The pharmacist must be available to assist the patient with Schedule III medication selection and
must be involved in the sale of Schedule II medications. The practice directions Sale of Schedule 2
Drugs and Sale of Schedule 3 Drugs should be reviewed.
Communication and Education 45

8. Intra- and Inter-Professional Collaboration
Pharmacists work in collaboration with the pharmacy team and other health professionals to
deliver comprehensive services, make best use of resources and ensure continuity of care in
order to achieve the patient’s health goals.
Key Competencies
8.1 Create and maintain collaborative professional relationships.
8.2 Contribute to the effectiveness of working relationships in collaborative teams.
8.3 Participate in the delivery of collaborative health services.
8.4 Accept and make referrals for specific services.
Communication with health care professionals
The pharmacist is a frequently visited healthcare professional, they often act as a liaison between
the patient and other members of the healthcare team. It is important that the intern advocates
for the patient when necessary, relaying crucial information to the patient’s healthcare team. At
all times the intern must remain respectful and professional in their demeanor and approach to
providing recommendations to other healthcare professionals. Professional ethics are described in
Section 76 of the Pharmaceutical Act, and the Ethical, Legal and Professional Responsibilities
section of this manual. The Code of Ethics and Explanatory Document should be reviewed by the
intern and preceptor.
Occasionally, the pharmacist may question a prescribed medication or treatment plan. The
prescriber must be contacted to verify the medication or treatment. Ensure to handle these
situations professionally and never discredit other health professionals to the patient. The
patient's well-being is always the priority. The intern needs to be able to identify and make
appropriate referrals to practitioners.
The following interactions with other healthcare providers are common and should be reviewed
with the intern:
 Accepting verbal prescription orders from the prescriber.

 Clarifying unusual dosage (high or low).
 Requesting clarification in cases of possible therapeutic problems, errors of omission or
commission, and communicating therapy recommendations to the prescriber.
 Consulting with the prescriber in cases of drug under or over utilization by patient.
 Contacting the prescriber in case of suspected adverse drug reaction or side
effect/toxicity and interactions.
 Providing drug information (e.g. composition, availability, dose, use, classification,
nomenclature, administration techniques and special formulations).
 Informing the practitioner of any prescriptions that may have been adapted or renewed
Intra- and Inter-Professional Collaboration

through continued care.
 Notifying the prescriber of any medications prescribed by the pharmacist or lab tests
ordered and the results of the tests.
Other Prescribers
Presently within the Canadian healthcare system, there is a movement towards inter-professional
teams of health providers working together in the community and in institutional settings to
provide collaborative patient-centred care. Evidence exists to support that collaborative patient-
centred care improves patient safety and health outcomes.
Midwives are able to prescribe medication from an approved list, which can be found on the
College website. The prescriber number under DPIN is prefixed by an “M”. The prescription
medication label should indicate the name of the midwife prefaced by the letter “MW” (rather
than “DR”).
Registered Nurses (Extended Practice) and Nurse Practitioners are also able to prescribe
medication to their patients. Nurse practitioners and RN (EP)’s must indicate on the prescription
the treatment goal, diagnosis and/or clinical outcome. RN (EP)’s have their own prescriber number
under DPIN. Nurses with prescribing rights in other provinces can issue prescriptions to be filled in
Manitoba. Verification of the practitioner’s authority to prescribe is a key task and should be
discussed with the intern. In order to obtain authority to prescribe narcotic, controlled drugs and
benzodiazepines, RN (EP)’s must complete additional training and have the condition removed
from their license by their regulatory body. Verification of this additional authority in Manitoba
can be checked on the College of Registered Nurses of Manitoba website (www.crnm.mb.ca)
under the NurseCheck directory.
Clinical assistants, physician assistants and graduate medical students on the educational
register are permitted to receive prescribing rights through the delegation of a medical
practitioner (supervising physician). The treatment goal, diagnosis and/or clinical outcome must be
indicated on the prescription, as well as the name of the supervising/attending physician. Entries
of these prescriptions in DPIN are under the license number of the attending physician.
Optometrists can register for one of two classes of optometric drug licenses: Therapeutic or
Diagnostic. Optometrists who have a Therapeutic licence issued by the Manitoba Association of
Optometrists (MAO) can prescribe medications listed in Schedule A of the Regulations under The
Optometry Amendment Act. Schedule A includes all topical over-the-counter and prescription eye
medications as well as oral medications for glaucoma. Oral antibiotics can only be prescribed for
treatment of chronic eyelid diseases. In cases such as treatment of glaucoma, the optometrist
must consult and collaborate with an ophthalmologist. Pharmacists can verify an optometrist’s
therapeutic license by checking the register on the MAO website (www.optometrists.mb.ca). For
DPIN entry, the pharmacy will use the designation “E” followed by the optometrist’s DPIN
prescriber number.

Dentists can prescribe medication within the scope of their dental practice. Prescriptions must be
for treatment related to dental health, procedures or surgery. The prescriber number under DPIN
is prefixed by a “D”. Smoking cessation medication can be prescribed once an educational program
has been completed by the dentist and the dentist should provide follow-up and monitoring with
the patient.
Veterinarians can prescribe within the scope of their veterinarian practice only. Prescriptions must
be for animal, fish or fowl. They have the designation “DVM” and are authorized to prescribe
controlled drugs and narcotics. DPIN entry for veterinary prescriptions is not required.
Pharmacists must use their five digit license number with the prefix “X” as their prescriber number
(e.g. X12345) when entering a prescription into DPIN that has been prescribed by the pharmacist.
In addition to prescribing a schedule II or III drug, medical device, or for a condition in Schedule 3
to the Regulation, pharmacist prescribing occurs when authorizing a continued care prescription,
or when adapting a prescription. The treatment goal, diagnosis or clinical indication must be
included on the prescription written by a pharmacist.
It is important to note that midwives, clinical assistants, physician assistants, graduate medical
students on the educational register, optometrists and pharmacists cannot prescribe narcotic,
controlled drugs or benzodiazepines.
The Prescribing Authority Table and prescriber webpage on the College’s website provide
additional information on prescribing authority, requirements and limitations on prescribing, as
well as links to the respective regulatory bodies.

9. Quality and Safety
Pharmacists collaborate in developing, implementing, and evaluating policies, procedures and

activities that promote quality and safety.
Key Competencies
9.1 Contribute to a culture of patient safety.
9.2 Contribute to continuous quality improvement and risk management activities
related to pharmacy practice.
9.3 Ensure the quality, safety and integrity of products.
9.4 Create and maintain a working environment that promotes safety.
Ensuring Quality Pharmacy Practice
Quality in all areas of pharmacy practice may be seen as the layers of practice that support safe,
patient-centered and progressive pharmacy practice. The layers that comprise pharmacy
practice include: pharmacy practice site environment, rules and standards governing pharmacy
practice, pharmacist competence, and the desire to continually improve one’s practice in order
to affect positive health outcomes for patients.
1. Pharmacy Site Requirements
The environment of the pharmacy practice site can greatly influence the pharmacist’s
ability to provide quality pharmacy care. Requirements for adequate space,
equipment, lighting and resources are only a few of the site requirements that have
been established to enable the pharmacist to practice effectively and safely.
2. Practice Support
Legislation, standards of practice, guidelines and joint statements with other health
professions help guide pharmacists in the provision of quality pharmacy care.
Pharmacists, pharmacy managers and College field office staff assess pharmacy site
requirements and practice support through the Pharmacy Quality Assurance Self-
Assessment and onsite regular inspection process.
3. Competence
Prior to initial licensing with the College, all pharmacists must successfully complete
the PEBC qualification examination. As with all health professionals, maintaining
competence within our dynamic healthcare system requires pharmacists to
continually upgrade their knowledge and skills through continuing professional
Intern’s Self-Assessment 49
development (CPD). Pharmacists in Manitoba rely on the College Learning Portfolio
System to assist them in planning for, participating in and reflecting on their CPD. The
self-assessment component of the Learning Portfolio is a tool to assist pharmacists in
identifying their learning needs. The onsite regular inspection process provides an
additional opportunity for pharmacists to identify learning needs.
The College recognizes the need to strengthen the self-assessment process and to
provide pharmacists with assessment tools that are more informative and relevant to
the actual practice environment. Currently much work is underway across the
country and in Manitoba to develop performance-based assessment models that will
more closely mirror real life pharmacy practice and provide an objective and
perceptive evaluation of a pharmacist’s practice to identify strengths and areas for
improvement.
4. Continuous Quality Improvement
The Continuous Quality Improvement (CQI) concept is an approach to quality that

strives for excellence in practice and improved patient health outcomes. CQI involves
examining pharmacy processes to identify and learn from inefficiencies and
medication incidents in order to develop efficient processes that improve patient
care and safety. An understanding of patient needs and expectations is key to
achieving positive outcomes. The patient's role in decisions regarding their
healthcare cannot be understated.
Medication Incidents and Discrepancies or Near Miss Events
Despite the careful precautions exercised, all pharmacists occasionally make mistakes. When an
error is discovered, the pharmacist must deal with the problem in a professional manner. The
first priority is to assess the risk to the patient and to ensure the patient receives the correctly
labelled medication.
The Incidents and Discrepancies Practice Direction should be reviewed by the intern.
All Areas of Practice (Hospital, Community and Clinical):
1) Medications shall be prepared and dispensed according to established procedures that

ensure the medication for administration to patients is accurate and safe, and delivered in
a timely manner. Failing this, the following definitions apply:
 Medication incident: Any preventable event that may cause or lead to
inappropriate drug use or patient harm while the drug is in the control of the
health professional, patient, or consumer. Medication incidents may be related to
professional practice, drug products, procedures, and systems, and include
prescribing, order communication, product labelling/packaging/nomenclature,
compounding, dispensing, distribution, administration, education, monitoring, and
use.
 Medication discrepancy or near miss: An event or circumstance that took place,
and could have resulted in an unintended or undesired outcome(s), but was
discovered before reaching the patient.
2) All medication incidents are to be documented at the first available time on an incident
report form. Discrepancies or near misses may be documented at the pharmacist’s
discretion, however a review of discrepancies may result in development of procedure
changes to prevent re-occurrence of the event.
Community pharmacy:
1. All medication incidents shall be given priority over any other non-emergency tasks and
duties. The pharmacist discovering the incident must determine if the patient has
experienced harm or is at risk of possible harm.
2. The patient shall be contacted and advised immediately of a medication incident. Should
immediate patient contact not be obtained easily, every effort must be made to locate and
contact the patient.
3. The pharmacist must ensure the patient receives the right medication in a timely manner.
The pharmacist should acknowledge the incident to the patient and express appropriate
empathy. The pharmacist that discovers the medication incident must ensure the incorrect
medication is quarantined and/or returned to the pharmacy to avoid risk of further harm.
All medication incidents must be documented promptly on a numbered pharmacy incident
report form. The pharmacy incident report form shall include, at minimum, the date,
prescription number, incident number and a brief summary of the incident. The
incident report forms are retained by the pharmacy and assessed periodically.
 The patient should be made aware that the incident will be forwarded to the
appropriate parties, for example the pharmacy manager and prescribing
physician.
4. Strategic changes in dispensing procedures and provision of medication by the pharmacy
shall be implemented in an effort to prevent the reoccurrence of medication incidents and
discrepancies.
Hospital pharmacy, personal care home, and long term care facility:
1) When a medication incident or discrepancy is discovered, the following (as appropriate)

shall be notified as soon as possible: head/charge nurse, attending physician, and
pharmacy department.
2) The pharmacist must determine if the patient has experienced or is at risk of experiencing
harm.
3) The pharmacist must provide care for the patient as appropriate to protect the patient’s
health and safety.
4) Pharmacists must adhere to the organizations/pharmacy’s policies and procedures for
patient disclosure, reporting, investigating, documenting, and sharing lessons learned.
5) Pharmacists must participate in a process to review medication incidents with a
multidisciplinary team.
The Apology Act has been put in place to ensure that the pharmacist can immediately apologize
and inform the patient of the error without concern of liability. The purpose of this is to promote
transparency, while resolving the medication incident. The intern should review this legislation and
how it pertains to medication incidents.
Conclusion
This Manual has outlined various components of pharmacy practice for review and discussion
with your preceptor with the intent of helping you to develop the knowledge, skills and
abilities, especially communication, required to practice pharmaceutical care for the
betterment of the public you will serve on a daily basis.
Intern’s Self-Assessment
and Personal Learning Plan
Introduction
The entry level pharmacist must have a basic level of competence. One of your new
professional responsibilities is determining whether you are competent to perform specific
functions or jobs. This means taking an honest and critical look at your knowledge, skills, and
experience.
Self-assessment is key to understanding your own practice strengths and limitations. Life-long
learning refers to a process of learning that continues throughout our lives. Life-long learning
and professional self-assessment are closely linked. Rather than being told what to learn, self-
assessment allows you to take responsibility for identifying your personal learning needs,
developing personal learning plans and evaluating your learning outcomes. In order to maintain
your competence, it is vital that you continue to learn and improve your skills throughout your
pharmacy career.
Self-assessment is built into your internship. To gauge your readiness for practice, complete this
self-assessment at the beginning of the internship, in the middle, and at the end. The self-
assessment is based on NAPRA’s Professional Competencies for Canadian Pharmacists at Entry
to Practice. Add comments, exercises, or ideas after each section that may assist you in
improving your current practice. Use these comments to develop goals for your learning. This
action plan can be recorded on the Personal Learning Plan template found in this Manual.
Note: This self-assessment is for your own learning purposes and does not need to be submitted to the
College.
Please use the following rating scale to gauge your performance in the competency areas:
Rating Scale
I require more education, practice, and training in order to
1 Developmental
perform this competency safely and with confidence.
I have areas of weakness in knowledge, skills, attitudes or
clinical judgements and require more practice to perform
2 Requires improvement
this competency. I require some guidance to perform this
competency.
I meet the expectations and can confidently perform this
3 Competent
competency without guidance.
I demonstrate excellence in this competency. I can perform
this area of practice without guidance or supervision and
4 Excellent
would be confident in teaching another pharmacy student
or intern this skill.
I have not yet had an opportunity to perform this
N/O No opportunity
competency.
Competency 1: Ethical, Legal and Professional Responsibilities
Pharmacists practise within legal requirements, demonstrate professionalism and uphold
Key Competency Please rate your performance in the following areas: Intern’s Rating
1.1 Practice within Applies legal requirements to practice, including occupational
legal requirements. health and safety legislation, privacy legislation, federal and 1 2 3 4 N/O
provincial legislation and all other related by-laws and standards.
1.2 Uphold ethical Applies principles of professional codes of ethics and applies these
principles. 1 2 3 4 N/O
principles in the decision-making process.
Demonstrates professional integrity by practicing within personal
1 2 3 4 N/O
limits of knowledge, skills and abilities.
1.3 Manage actual and
potential illegal,
unethical, or Able to appropriately identify and address illegal, unethical or
1 2 3 4 N/O
unprofessional actions unprofessional actions or situations.
or situations in the
workplace.
1.4 Apply principles of Accepts responsibility for own actions and decisions. 1 2 3 4 N/O
professionalism.
Seeks guidance when uncertain about own knowledge, skills,
1 2 3 4 N/O
abilities and scope of practice.
Able to assess own learning needs and develop a learning plan
1 2 3 4 N/O
accordingly.
Exhibits professionalism in appearance, attitude and punctuality. 1 2 3 4 N/O
Maintains a professional relationship and appropriate boundaries
with the staff, peers, other healthcare professionals, and the 1 2 3 4 N/O
public.
Protects the privacy and confidentiality of the patient. 1 2 3 4 N/O
Identifies and manages situations of conflict of interest. 1 2 3 4 N/O
Describes the Canadian healthcare system and the roles various
1 2 3 4 N/O
healthcare professionals fulfill.
1.5 Document
Maintains complete, accurate and secure patient records. 1 2 3 4 N/O
activities of practice in
compliance with Identifies situations in which documentation should and should
legislation, standards not be shared, as well as the appropriate method with which to 1 2 3 4 N/O
and policies. share, with other health professionals or third parties.
COMMENTS:
Competency 2: Patient Care
Pharmacists, in partnership with patients and other healthcare professionals, meet the patient’s
health and drug-related needs and to achieve the patient’s health goals.
2.1 Develop a Establishes and maintains trusting professional relationships with
professional 1 2 3 4 N/O
patients by using effective communication skills.
relationship with the
Demonstrates a caring, empathetic, and professional attitude. 1 2 3 4 N/O
patient.
Determines and acknowledges the patient’s needs, values and
health care goals and respects the roles of each party in the 1 2 3 4 N/O
relationship.
2.2 Obtain Gathers patient information, using appropriate sources of
information about the information, by actively listening and interpreting information 1 2 3 4 N/O
patient. provided. Organizes and records the patient’s information.
2.3 Assess the Assesses the patient’s health and drug-related needs, as expressed
patient’s health status by the patient, considering the impact of factors such as culture, 1 2 3 4 N/O
and concerns. language, demographic and physical characteristics.
Makes appropriate recommendations based on relevant
1 2 3 4 N/O
laboratory tests and other diagnostic assessments.
Performs medication reconciliation. 1 2 3 4 N/O
Assesses the patient’s ability to access and use his or her
1 2 3 4 N/O
medication.
2.4 Determine the
Identifies and prioritizes actual and potential drug therapy
patient’s actual and
problems and consults with the patient and, if necessary, other 1 2 3 4 N/O
potential drug therapy
healthcare professionals.
problems.
2.5 Develop the Determines the patient’s health goals and optimal therapeutic
patient’s care plan. outcomes, specifying measurable endpoints, target values and 1 2 3 4 N/O
timeframes.
Develops a therapeutic plan by determining patients’ health goals
and optimal therapeutic outcomes and identifying best available
1 2 3 4 N/O
treatment strategies (including drug and non-drug measures) using
an evidence-informed approach.
Provides effective patient education including risks and benefits,
to support the patient in making informed decisions about their 1 2 3 4 N/O
care plan.
Involves the patient in decision-making and respects the patient’s
1 2 3 4 N/O
right to make choices.
Assesses the patient’s understanding of the therapeutic plan. 1 2 3 4 N/O
2.6 Implement the Undertakes actions outlined in the care plan, including: prescribing
patient’s care plan. 1 2 3 4 N/O
and adapting prescriptions.
2.7 Administer drugs
to the patient using
Administers drugs by injection, or another appropriate route, using
the necessary
the necessary technical skills and applying the appropriate clinical 1 2 3 4 N/O
technical skills/
knowledge, if authorized to do so.
applying appropriate
clinical knowledge.
2.8 Monitor the Monitors patient progress and assesses therapeutic outcomes by:
patient’s progress and
i) Reviewing and discussing with the patient the important
assess therapeutic 1 2 3 4 N/O
monitoring parameters and timelines.
outcomes.
ii) Assessing adherence, tolerance and safety of therapy. 1 2 3 4 N/O
iii) Following-up with patient to evaluate the therapeutic
1 2 3 4 N/O
effectiveness and revise when necessary.
COMMENTS:
Competency 3: Product Distribution

Pharmacists ensure accurate product distribution that is safe and appropriate to the patient.
3.1 Dispense a product Addresses concerns related to validity, clarity, completeness, and
safely and accurately 1 2 3 4 N/O
authenticity of the prescription.
that is appropriate for
Selects appropriate products and ingredients using knowledge of
the patient.
bio-equivalency, therapeutic equivalency, interchangeability, 1 2 3 4 N/O
quality, integrity and stability of drugs.
Performs pharmaceutical calculations and compounding (including
1 2 3 4 N/O
documentation).
Is able to supervise support staff during drug distribution activities. 1 2 3 4 N/O
Participates in continuous quality assurance by responding to

actual or potential problems within the drug distribution system
1 2 3 4 N/O
and implements measures to prevent occurrences or
reoccurrences.
Develops master compounding formulas and prepares and

compounds non-sterile products according to recognized 1 2 3 4 N/O
guidelines and standards of practice.
Identifies and addresses patterns of unusual drug prescribing and

1 2 3 4 N/O
usage including possible diversion or drug misuse.
Checks the product and its prescription label against the

prescription using a systematic approach, including an 1 2 3 4 N/O
independent double check.
COMMENTS:
Competency 4: Practice Setting
patient care.
4.1 Optimize the Demonstrates the organizational and time management skills
safety, efficacy and necessary to effectively prioritize, organize and manage patient 1 2 3 4 N/O
efficiency of care.
operations in the
Manages support personnel such that assigned functions are
practice setting. 1 2 3 4 N/O
carried out to meet accepted standards.
Assesses the impact of automation and other technology in the
practice setting on the safety, efficacy and efficiency of patient 1 2 3 4 N/O
care.
4.2 Oversee pharmacy Develops procedures to ensure the return or proper disposal of
1 2 3 4 N/O
inventory to ensure recalled, expired and unusable products.
safe, effective, and
Supervises controlled substances in the practice setting by
efficient patient care. 1 2 3 4 N/O
ensuring auditing and resolving or reporting discrepancies.
Ensures inventory is received from legitimate sources, addresses
issues with drug supply chain verifying that stability requirements
are met. For example cold chain is maintained, drug shortages and 1 2 3 4 N/O
recalls are managed and controlled substances are submitted to
audits regularly.
4.3 Oversee record Recommends appropriate record-keeping procedures and
keeping activities to technologies for maintaining the integrity, security and
ensure safe, effective permanence of records in the practice setting. Addresses any 1 2 3 4 N/O
and efficient patient barriers to safe and effective patient care arising from health
care. information technology.
COMMENTS:
Competency 5: Health Promotion

and populations.
5.1 Engage in health Assesses the primary health needs of the patient, considering
promotion activities factors such as socio-economic status, culture, language and
with the patient. 1 2 3 4 N/O
environment that are barriers to, or facilitators of, health and
wellness for the patient.
Collaborates with the patient and other health professionals to
develop and implement patient-specific health promotion
1 2 3 4 N/O
strategies and routinely provides advice and delivers patient-based
clinical preventative services.
Facilitates the patient’s access to and interaction with support
1 2 3 4 N/O
agencies and health services.
5.2 Participate in
Participates in organized initiatives for disaster, pandemic and
public health 1 2 3 4 N/O
emergency preparedness.
activities.
5.3 Contribute to the
Promotes public awareness of the proper handling and disposal of
maintenance of a
drugs and hazardous materials. Identifies and minimizes the risk of 1 2 3 4 N/O
healthy environment
disease transmission from the pharmacy environment.
for the public.
COMMENTS:
Competency 6: Knowledge and Research Application

Pharmacists access, retrieve, critically analyze and apply relevant information to make evidence-
informed decisions within their practice with the goal of ensuring safe and effective patient
care.
6.1 Apply knowledge, Critically analyzes and develops solutions to problems in pharmacy
research skills and 1 2 3 4 N/O
practice.
professional
Makes decisions using an evidence-based approach. 1 2 3 4 N/O
judgement to the
decision-making Rationalizes recommendations and decisions with critically
1 2 3 4 N/O
process. analyzed evidence and accurate and clear explanations.
6.2 Respond to Uses a variety of retrieval techniques and references to access
questions using 1 2 3 4 N/O
reliable and relevant information.
appropriate strategies.
Analyzes, evaluates and interprets the researched information and
composes an appropriate response to the question. Ensures that 1 2 3 4 N/O
the information provided is current, reliable and relevant.
COMMENTS:
Competency 7: Communication and Education
7.1 Establish and
maintain effective Demonstrates proficiency in written and verbal English or French. 1 2 3 4 N/O
communication skills.
Demonstrates effective communication skills including appropriate
verbal, non-verbal and listening skills and effective interview 1 2 3 4 N/O
techniques.
Demonstrates sensitivity, respect and empathy when

1 2 3 4 N/O
communicating.
7.2 Implement safe, Communicates in a way that maximizes safety and understanding,
effective and including repeating back verbal orders, using recognized 1 2 3 4 N/O
consistent terminology and avoiding unnecessary or unsafe abbreviations.
communication
Implements an accessible and consistent method for storing
systems. 1 2 3 4 N/O
information that can be retrieved by relevant personnel.
7.3 Deliver an
education session to Educates an individual or a group and selects materials that are
1 2 3 4 N/O
an individual or a appropriate for the learner(s)/patient(s).
group.
COMMENTS:
Competency 8: Intra and Inter-Professional Collaboration

Pharmacists work in collaboration with the pharmacy team and other healthcare professionals
to deliver comprehensive services, make best use of resources, and ensure continuity of care in
8.1 Create and
maintain collaborative Collaborates with other parties in the relationship to define the
1 2 3 4 N/O
professional roles and responsibilities of each party.
relationships.
Demonstrates leadership qualities in team activities. 1 2 3 4 N/O
effectiveness of
working relationships Shares decision-making activities with other team members. 1 2 3 4 N/O
in collaborative teams.
Interacts respectfully with other members of the team by
accepting accountability for themselves and managing 1 2 3 4 N/O
disagreements and conflict in a professional manner.
8.3 Participate in the Participates in patient assessment and develops a care plan in
delivery of collaboration with the patient and other members of the team.
collaborative health 1 2 3 4 N/O
Implements and monitors the sections of the care plan that are
services. the pharmacists’ responsibility.
8.4 Accept and make Recognizes signs, symptoms and risk factors indicative of health
referrals for specific needs that fall beyond the scope of pharmacy practice. Refers
services. 1 2 3 4 N/O
patients to other healthcare providers when it is appropriate to do
so.
COMMENTS:
Competency 9: Quality and Safety

9.1 Contribute to a Effectively informs a patient of the occurrence of a medication
culture of patient 1 2 3 4 N/O
incident or adverse drug event.
safety.
Shares information about problems and resolutions with the
1 2 3 4 N/O
workplace team.
9.2 Contribute to Anticipates, recognizes and manages situations that place the
continuous quality 1 2 3 4 N/O
patient at risk.
improvement and risk
management activities Identifies the occurrence of a medication incident, adverse drug
related to pharmacy event or close call and responds effectively to mitigate harm and 1 2 3 4 N/O
practice. prevent reoccurrence.
9.3 Ensure the quality, Ensures the cleanliness of the dispensary and that products are
safety and integrity of stored and transported under the conditions required to maintain
products. 1 2 3 4 N/O
product quality, safety and integrity, including cold chain
management.
9.4 Create and Minimizes and manages distractions in the work environment. 1 2 3 4 N/O
maintain a working
Handles hazardous products safely by minimizing personal
environment that 1 2 3 4 N/O
exposure and reducing environmental contamination.
promotes safety.
Manages factors that affect personal wellness including work-life
1 2 3 4 N/O
balance, sleep deprivation and physical and emotional health.
COMMENTS:
Feedback and Review of Learning Goals
Self-assessment is key to understanding your own practice strengths and limitations. However,
feedback from your preceptor, pharmacists and other health professionals you encounter can
be equally important and valuable. Feedback is vital to the ongoing improvement of interns in
the practice setting.
Ask your preceptor, coworkers, or other healthcare professionals to fill out this form and
provide you with constructive feedback to assist you in improving your current practice. Use
these comments to reflect on your performance and develop or adapt your goals for your
learning. These goals and the results of the self-assessment can be recorded on the Personal
Learning Plan found in this Manual.
Please note that this form does not need to be submitted to the College.
Date: _______________________________
Name of Reviewer: _____________________________________
Position: _____________________________________
Area of Practice and Activities Performed:
Areas of Strength:
Areas of Improvement:
General Comments:
Feedback and Review of Learning Goals 62

Personal Learning Plan
Learning Goals: Action Plan: Resources: Learning Outcome:
What areas do I want to What exercises or activities What resources could I Am I confident in my ability?
gain more experience in? would help me? use? Do I need more experience?
Personal Learning Plan 63

Demonstration of Product Release Proficiency
The demonstration of product release proficiency (DPRP) is a process where a pharmacy intern’s
ability to accurately and consistently perform a technical check of a drug preparation or
prescription is verified by an evaluator. The evaluator may be the preceptor or another licensed
pharmacist at the rotation site. The items that the intern checks must be evaluated by the
evaluator pharmacist using an independent double check. Such verification can be performed in
the presence or absence of the intern. In either case, the most critical aspect is to ensure that the
intern does not communicate what he or she expects the checking pharmacist to see, which would
create bias and reduce the visibility of an error.
Following graduation and successful completion of the DPRP, the preceptor may authorize the
postgraduate intern to perform final checks independently and under indirect supervision (i.e.
without being double checked by the preceptor or another pharmacist). The preceptor must be
confident in the intern’s skills, abilities and judgements prior to permitting this additional
responsibility.
The DPRP can be initiated at any time during the internship, given the intern has the skills and
knowledge required to perform the activity. The preceptor must be confident in the intern’s
abilities and must approve the start of the DPRP. The DPRP must be successfully completed in
order for the internship to be successfully completed.
Prior to beginning this exercise, the preceptor and intern must discuss the expectations of the
intern with respect to the checking process. There should be a clear understanding between the
preceptor and intern regarding:
 What is considered an error in the checking process, and
 The procedure that will be followed if the intern misses an error that was made in the
filling process. This procedure should include the steps that the intern will take to ensure
the error will be prevented in the future.
The pharmacy intern must demonstrate proficiency in product release by completing a

minimum of 200 consecutive checks with 100% accuracy. A maximum of 50 checks may be
completed per day. All types of prescriptions should be checked in this activity, including
prescriptions for narcotics, controlled substances, compounded preparations, repeat prescriptions,
and unit dose packages (if applicable). These various types of prescriptions should be checked in
the same proportion as seen in practice under normal working conditions. For example, if the
internship is at a site where 80% of the prescriptions are sterile preparations, 10% non-sterile
compounds and 10% dose packages, the intern must check approximately 160 sterile
preparations, 20 non-sterile compounds and 20 dose packages. Checking of batch prepared unit
dose drugs counts towards the 200 checks, but should only be a small portion.
If the intern makes an error, the checking process must be restarted at zero (for example, if the
intern accurately checks 195 prescriptions and then makes an error, the activity must be
restarted). If an error is made, the preceptor and intern must have a detailed discussion to identify
Demonstration of Product Release Proficiency 64

what part of the checking process should be re-evaluated and determine what steps the intern can
implement to minimize the risk of it reoccurring. This discussion should also include development
of a learning action plan to help monitor the intern’s learning goals and progress. A Personal
Learning Plan template can be found in this Manual.
After the intern makes an error in the checking process, the preceptor may require more than 200
consecutive checks to be accurately performed on the second attempt. The preceptor will
determine the number of extra checks based on the intern’s level of competency and how much
practice is required to achieve excellence. The intern is given a maximum of three attempts to
attain a minimum of 200 checks with 100% accuracy.
The progress of the DPRP can be recorded in a daily tracking log, which is supplied at the end of
this manual. The DPRP daily tracking log does not have to be submitted to the College. Rather, the
log should be retained for the intern’s records and be available on demand, as the log may be
requested by the College at any time. The intern must start a new tracking log each day to record
all checked prescriptions and any identified errors. The evaluator must independently double
check the items checked by the intern and initial one of the following options:
 “No error missed” if:
o The intern correctly identified there was no error in the prepared prescription; or
o The intern correctly identified an error in the prepared prescription.
 “Error missed” if:
o The intern did not appropriately identify an error in the prepared prescription.
Upon completion of the DPRP, the preceptor should ensure the intern continues to have
opportunities to perform all aspects of pharmacy practice and not simply the technical checking
component. Interns should participate in all the various competencies on a daily basis (as
available). A daily limit of final checks should be set in order that the intern is not solely
performing final checks, but also participating in other pharmacist activities.
Successful completion of the DPRP is declared by the preceptor in the Statement of Completion of
Internship form, which is included in the Evaluation Forms section of the manual. This form must
be submitted at the end of the internship along with the feedback forms and final evaluation.
The Technical Checking Process
When verifying the technical accuracy of a prescription, applicable legislation surrounding the
appropriateness of the order is paramount. This must be determined before other checks, as
described below, are performed.
When checking the medication to be dispensed, the label and medication should always be
checked against the prescription. The order in which these checks are carried out may vary but

all of the following checks must be performed on each prescription:
a) Right patient
b) Right drug, dosage form and route
c) Right dose and quantity
d) Right directions
e) Right prescriber
f) Additional considerations
Depending on the workplace, a different set of “rights” may be used. This is acceptable as long
as all the appropriate checks are completed.
The following process may be used as a reference for checking community and/or hospital
prescriptions, orders, vials, compounds, unit dose bins, blister packing and other compliance
packaging, or other similar processes. All steps may not be applicable to all practice settings, so
the intern and evaluator/preceptor may need to adapt the checking process to be workplace
specific.
a) Right patient
 Check the patient’s name on the prescription/order and vial/product label for accuracy.
Be extra vigilant when there are duplicate names in the pharmacy computer system.
 Check the patient’s address and date of birth. Always check two identifiers.
 (Hospital) Check that the bin/card/product item, etc. has been labelled with the correct
patient name, room number and floor.
b) Right drug, dosage form, and route

 Ensure that the drug name on the prescription/order matches the name on the
vial/product label and with the stock bottle being used (with allowance for generic
substitution). Pay particular attention to drugs that have similar names to ensure the
correct drug is dispensed.
 Refer to the Manitoba Interchangeability Formulary to determine if a generic drug is
available.
 (Hospital) Follow automatic substitution (generic and therapeutic) policies as applicable.
 Match the DIN on the prescription hard copy to the label on the manufacturer’s stock.
 Check that the dosage form matches the form stated on the prescription.
 Check the physical appearance of the drug to ensure the product is what the label states
and is of good quality.
 Ensure integrity of the final product.

 Check the expiration date on the manufacturer’s stock bottle to ensure the product will
not expire during the treatment period. Take extra care with liquids which may have a
shorter shelf life once the stock bottle has been opened.
 Check if the medication is a high alert or high risk medication that may need further
checks.
c) Right dose and quantity

 Ensure the strength and dose on the prescription have been interpreted correctly.
 Check calculations for dosage, compounding, etc.
 Ensure the quantity on the prescription and vial label are the same. If the quantity has
been calculated from information on the prescription, double check the calculation.
 Ensure the number of refills on the prescription and product are the same.
 (Hospital) Ensure the product and quantity have been correctly selected and placed into
the correct bin/card/bag/etc.
 Check that the quantity of the product matches the quantity on the pick list/medication
administration record (MAR)/label or other form of checking list.
d) Right directions
 Verify that the directions on the prescription provide the same dose as what is stated on
the vial/product label.
 Ensure that the directions and label are clear and easy to understand.
 Confirm the dosing interval and frequency.
 (Hospital) Check that administration times have been respected according to the system
in place (e.g. scheduled doses in front, prn doses in back).
e) Right prescriber
 Ensure the prescriber’s name and information is correct on the prescription and product
label.
 Ensure prescribing laws and regulations are followed (i.e. scope, authority, prescribing
conditions, etc.).
f) Additional considerations
 Check that the most appropriate packaging/container has been used.
 Ensure the proper auxiliary labels are used.
 Ensure that the prescription is in compliance with provincial legislation regarding drug
dispensing (e.g. labeling, pricing, etc.).
 Ensure all documentation has been completed and properly filed.

 Take responsibility for the accuracy of the filling and distribution process.
 Bring any drug related problems to the pharmacist’s attention.
 Ensure proper storage conditions.

Demonstration of Product Release Proficiency Daily Tracking Log
Check prescriptions to ensure the correct: patient, drug, dosage form, route, dose, quantity, directions, prescriber, and container/packaging
Ensure that prescriptions are filled and checked to be in compliance with regulations and policies regarding the dispensing of drugs.
Use a new Daily Tracking Log each day to record all items checked by the intern (maximum of 50 per day). The intern is required to complete a total of 200
checks without making any errors in order to satisfy the SPT Program requirements. All checks are to be recorded on this log, along with all details of any
errors missed by the intern. The DPRP daily tracking log forms do not need to be submitted to the College, rather the intern should retain it for their own
records. The daily tracking log must be available for inspection on demand and may be requested by the College at any time.
Intern (fill in unshaded area): Use a new line for each prescription checked and if applicable, record the error identified during your technical check.
Evaluator (fill in grey shaded area): Initial either “no error missed” or “error missed”. If an error is missed, record the details and discuss with intern.
Date:
Name of intern: Evaluator:
Check # Rx # (if applicable) Record “No Error” or if error is Check No Error Error
Describe type of error missed by the
(MAX and type of items identified by intern, record complete Missed Missed
intern
50/day) checked type of error identified (initial) (initial) (initial)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
Case Scenarios
and
Questions for the Intern
71
Introduction
The following questions and scenarios are presented for discussion between the preceptor and the
intern. The intent is for the preceptor and the intern to discuss these scenarios and questions
within the context of the preceptor’s practice site.
The expectation is that the intern will research and make notes while discussing the case scenarios
and questions. The intern should keep these answers in a readily retrievable manner/format. The
answers should include, but not be limited to:
 How the intern would handle these situations.

 What advice the intern could or should provide.
 Any alternate ways of handling the situation.
 Any other applicable information.
Note: The answers do not need to be forwarded to the College of Pharmacists of Manitoba, but
must be available for inspection on demand. The intern should keep the answers on file for at least
one year.
The questions and scenarios are grouped as follows:
A. College Assignment
B. Pharmaceutical Care Plans
C. Communication Assignment
D. Non Prescription Drug Assignment
E. Community Assignment (to be completed by community interns)
F. Hospital Assignment (to be completed by hospital interns)
A. College Assignment
1. Define an exempted codeine product. Where must these be kept and why? What is the role and
responsibility of the pharmacist when a patient asks to purchase an exempted codeine
preparation? What assessment questions must a pharmacist ask during the assessment? What
documentation is required when prescribing/dispensing an exempted codeine preparation?
2. You are presented with a prescription that you suspect is a forgery. What action should you
take? Who should you inform and what information should you forward?
3. You are requested to telephone another pharmacy to obtain a transfer of a prescription. The
prescription is for Tylenol #3 that was originally part filled. Can you fill the prescription? If not,
what would you do? What documentation is required to transfer or receive a copy?
4. In considering the Personal Health Information Act (PHIA), list three circumstances where a
pharmacist can reveal personal health information without permission of the individual who is
subject of the health information.
Case Scenarios and Questions 72

5. A patient presents you with a prescription for a drug on Health Canada’s Prescription Drug List
written by a doctor or nurse practitioner from another province. Can you fill this prescription? If it
were from the Mayo Clinic, Rochester, Minnesota, could you fill it? How would you handle these
situations?
6. Describe how the Narcotic and Controlled Drug Accountability Guidelines are implemented in the
pharmacy.
7. Describe the refill history recording system that is implemented in the pharmacy.
8. Review the pharmacy’s compliance with the practice direction, Standard of Practice #15:
Pharmacy Facilities, and discuss how the pharmacy meets those standards. What changes would
you make if the pharmacy was remodelled?
9. All communication about a patient’s health must be conducted in a confidential manner. Describe
the different actions the pharmacist and pharmacy staff must take to maintain the patient’s
privacy. Describe the method of disposal of personal health records in the pharmacy and how it
complies with the Personal Health Information Act regarding storage time requirements and
proper disposal.
10. A pharmacy must comply with the national drug schedules pertaining to the sale of non-
prescription medications. Describe the location and conditions for sale of Schedule II and III
medications and how the location and conditions for sale are operationalized in the pharmacy.
Describe the counselling and documentation requirements.
11. Describe the regulations with respect to the pharmacist’s involvement with the sale of
pseudoephedrine.
12. Review the location and issues involving the sale of NAPRA’s (National Association of Pharmacy
Regulatory Authorities) unscheduled medication in the pharmacy.
13. Write a note regarding the duties that may be performed by a pharmacy technician, other
persons (including pharmacy assistant), intern and those that are restricted to a pharmacist.
14. Review the “Self Testing Products Guideline” as approved by the College and how they are
implemented in the pharmacy. Write a description of a “Diabetic Day” at the pharmacy including
set-up and compliance with the guidelines. What information must be documented for tests
interpreted by the pharmacist? What tests can be interpreted by a pharmacist?
15. Locate the most recent issues of the College Newsletter and Friday Five. What issues are identified
in the newsletter and what are the latest issues facing the profession?
16. a) A pharmacist must review a patient’s DPIN record. What are the circumstances under which
the DPIN record can be accessed by pharmacist or pharmacy technician? What documentation
is required? With whom can the pharmacist share the contents of the record? With whom can
it not be shared?

b) How can the DPIN-ER be accessed by a hospital pharmacist?
17. Where should the isopropyl alcohol and rubbing alcohol be stored in the pharmacy?
18. Review the practice direction, “Incidents and Discrepancies”. Have the preceptor play a patient
returning to the pharmacy after receiving the wrong medication due to an error in dispensing.
What does the intern say and do? What documentation is required? What are the reporting
and documentation requirements had the dispensing error occurred prior to patient receiving
the medication?
19. Have the intern describe one process or task in the pharmacy that could be improved to
reduce the likelihood of a medication error or patient care incident.
20. A pharmacy calls you and needs 30 tablets of Morphine Slow Release 60mg tablets to fill a
prescription. Can you supply the medication? What procedures must you follow if you supply
this medication?
21. You receive a M3P form imprinted with Dr. Smith’s name and address. Dr. Black is the locum
for Dr. Smith and has filled out and signed one of Dr. Smith’s M3P prescriptions for a patient’s
oxycodone renewal. What do you do?
22. A veterinarian wants to prescribe a narcotic covered by the M3P program for an animal. He
does not have an M3P pad. Does he need one? What should he do?
23. Describe the practice roles which all pharmacists can undertake and those which require
additional training as well as certification by the College.
24. What is an extended practice pharmacist? Describe their expanded authority and the
restrictions under which they can practise and prescribe.
25. A community or hospital pharmacy can receive an application for additional components of
the pharmacy. Describe the different components and if any apply to your internship
pharmacy.
26. Some prescribers are required to include the treatment goal or clinical indication on any
prescription they issue. What is the reason for this requirement and for which prescribers is
this a requirement?
27. Section 83 of the Regulations to the Pharmaceutical Act discusses ensuring patient safety. Review
this section and discuss how this can be complied with and documented in community and
hospital practice.
28. What are the requirements for a pharmacy to provide opioid replacement therapy (ORT)? What
medications are used for ORT? Who can prescribe these drugs?

B. Pharmaceutical Care Plans Assignment
For the following cases review the patient’s medications and list all potential drug-related problems and
develop a pharmacy care plan for each one.
Case 1. Mrs. Belliveau is a frail woman who now lives with her daughter’s family. Despite her
medical problems, Mrs. Belliveau is usually bright and always enjoys interacting with her
two young, active grandsons. Recently, however, Mrs. Belliveau can’t remember their
names, seems drowsy all day and is increasingly confused. Because of her mental
deterioration, she forgets to eat and has been losing weight. Mrs. Belliveau’s daughter is
very concerned and has brought all of her mother’s prescriptions to you for review.
Patient Record:
PATIENT: Belliveau, Nadine D.O.B.: 06 June 1954

Allergies: None known Weight: 41 kg
Chronic problems: atrial fib, stroke (1992), glaucoma, breast Ca (1990), joint pains
New problems: dementia, confusion, recent mental deterioration, weight loss
Drug Sig Start Stop

Digoxin 0.125 mg tab one tab daily not known
Furosemide 40 mg tab one tab daily not known
Pot. chloride 600 mg SR tab one tab daily not known
Prednisone 5 mg tab two tabs daily not known
Timolol 0.5% ophth sol’n two drops in each eye twice daily not known
Ranitidine 150 mg tab one tab twice daily not known
Tamoxifen 10 mg tab one tab twice daily not known
Multivitamin tab one tab daily not known
ApoCal® 500 mg tab one tab three times daily not known
Flurazepam 15 mg cap one cap at bedtime not known

Case 2. Mr. Parks is a resident in a long-term care facility. Since the death of his wife, he has been
profoundly depressed and states that he doesn’t really care if he lives or dies. Recently, he
seems confused at times and calls out the name of his wife, disturbing other residents and
staff. In addition, he has fallen on a number of occasions. The facility staff ask if any of his
medications could be causing some of his problems.
Profile of Long Term Care Medications
PATIENT: Parks, Edward D.O.B.: 12 Jan 1936

Allergies: NONE Weight: 86 kg
Chronic problems: HT, depression
Drug Sig Start Stop

Amitriptyline 50 mg tab one tab at bedtime 09 Sep 2015 21 Feb 2016
Multivitamin tab one tab daily 09 Sep 2015
Triazolam 0.25 mg tab one tab at bedtime 09 Sep 2015
Propranolol 40 mg tab one tab three times daily 09 Sep 2015
Hydrochlorothiazide 25 mg tab one tab daily 09 Sep 2015
Bowel protocol as directed 21 Nov 2017
Amitriptyline 50 mg tab two tabs at bedtime 21 Feb 2017
Chlorpromazine 25 mg tab one tab prn agitation 03 May 2018
Mupirocin oint apply to scrapes prn 03 May 2018

C. Communication Assignment
1. Document at least one noteworthy example of a counselling session you had with a patient for a
prescription drug as per the College’s counselling requirements.
2. Document at least one noteworthy example of a consultation you had regarding the choice of a
non-prescription drug.
3. Document at least one noteworthy example of a patient care intervention that involved
consultation with the prescriber and follow-up with the patient.
4. Document at least one noteworthy consultation regarding patient care and/or medication
management with a physician or other health professional (dentist, nurse, veterinarian,
pharmacist, midwife, etc.)
5. What barriers to effective communication with the patient and prescriber exist in the pharmacy?
In the hospital? How could you overcome these barriers?
6. In what ways can you improve patient compliance (include specific examples of compliance aids)?
What are the three questions each patient should be asked about the care/medication they
receive, according to the Manitoba Institute for Patient Safety?
7. What procedures do you follow if a prescription is incorrectly written by a prescriber?
8. During the course of a consultation with a physician, the physician requests from the preceptor
his/her name and license number. What should the response be?
9. A young woman receives her last authorized refill of her carbamazepine. When you mention
that she will need a new prescription next month, she responds, “I think that I am going to quit
taking it because I want to get pregnant.” Describe your pharmaceutical care process.
10. An insomnia sufferer asks about using melatonin. She wants to know how it works, what form and
dose to take and if there are any side effects. What would you tell her?
11. Describe the action you would take in each of the following scenarios:
a) A dentist calls to ask about the current recommendations for prophylaxis of bacterial
endocarditis. His patient is an adult male with a heart murmur who is allergic to amoxicillin.
What do you recommend?
b) A patient is concerned about the cost of his therapy. Explain the options available to him for
coverage or alternative therapy that he could discuss with his physician.
i. Describe your response to his concerns about the cost of his prescription and his
options for coverage.
ii. The brand of medication that the pharmacy usually carries is on back order. What do
you do?

c) A female patient presents a prescription from a dentist for:
Penicillin VK 600mg QID M: 10 days
Dr. C. M. (DDM)
When you fill the prescription, you note a penicillin allergy warning. Upon examination of the
patient profile you note “severe intolerance to erythromycin July 2010”. You also note that
she is currently taking Triphasil 21 day®, warfarin 5mg OD, and amlodipine 5mg OD. What is
your response to this situation?
d) A 52 year old woman with diabetes is being treated with a thiazide diuretic and lisinopril for
hypertension. She pays for her own medications. When she comes in for her second refill she
comments, “These drugs sure are expensive and they don’t make me feel very good. I don’t
know why I bother taking them.” Describe her potential drug-related problem and your
approach with her.
e) A 64 year old female, just discharged from the hospital following treatment for deep vein
thrombosis, presents a prescription for warfarin 5mg daily. She also requests Pepto Bismol®
and low dose coated ASA. What should you do?
f) A physician phones regarding a terminal cancer patient who has been taking hydromorphone
1mg 1 tab q4h prn for pain. The patient is not pain-free. The physician is considering
changing dosage to morphine long-acting tablets and fentanyl sustained-release patches and
asks for a dosage recommendation. What would you recommend?
g) A patient presents a prescription for erythromycin 500mg qid. The patient is currently taking
carbamazepine CR 400mg tablets every 12 hours and multivitamins once daily. Are there any
interactions that need to be addressed?
h) A 48-year old woman has a new prescription for conjugated estrogen and
medroxyprogesterone but isn’t sure she wants to start hormone replacement therapy. She is
considering trying herbal products first. Discuss with her the advantages and disadvantages
of herbal and prescription products.
i) A mother brings in a prescription for her 4 year old from a specialist for a 21 day supply of
amoxicillin suspension. She requests the price and says that she can't afford the entire
prescription. Can she take half? How do you respond?
j) A patient presents a new prescription for venlafaxine. Her record reveals recent prescriptions
for fluoxetine and she expresses concern about not taking it any more. She just read an
article in the local mental health newsletter about “withdrawal syndrome” following abrupt
discontinuation of fluoxetine. Can you assist this patient with her drug-related problem?
k) Write a brief note on what steps you would take in following up a suspected adverse drug
reaction.

l) A physician calls asking for your advice regarding the use of a pain medication, an anti-nausea
medication, and a blood pressure medication in a 28 week pregnant mother. What process
would you follow to provide information to the doctor?
m) A patient new to your pharmacy brings in a prescription for methadone witnessed daily
doses. They have never used methadone before. List in detail, the steps needed to set up the
patient at the pharmacy, and what needs to be covered in counselling the patient.
n) A concerned mother comes into your pharmacy and wants to know more about naloxone.
What information do you provide her? Where can she purchase naloxone?

D. Non-Prescription Drug Assignment
1. On Saturday night, J. P. comes into your pharmacy and asks you for the best remedy for a
toothache. He explains he cannot see his dentist until Monday morning. What would you
recommend?
2. A hockey player asks if there’s anything that he can use for his smelly feet. The other guys really
hassle him about the smell in the locker room. He says that his feet are also itchy and flaky. What
can he do?
3. A young mother is looking for Tylenol® drops for her four month old infant. You only have
Tempra®. What instructions would you give this customer? She also needs Tylenol® as suggested
by her physician for her 3 year old but wonders if ASA chewable would be better. What would you
recommend?
4. A father of a 10 year old and a 3 year old asks for medication for car sickness. What would you
recommend?
5. A young mother comes in on Saturday afternoon and states that her 6 month old baby had four
loose bowel movements since morning. What would you recommend she do?
6. An elderly woman shows you a bottle of 100 Benadryl® capsules and says that they’re the best
thing she’s found for getting to sleep. What advice would you give her?
7. A young female customer approaches your dispensary and asks to purchase Wake-ups® and a
generic sleeping aid as she is in the middle of exams and needs to get through the next few weeks.
How would you respond to this customer?
8. A mother suspects that her five year old (21 kg) child has pinworms. How would you decide
whether treatment is warranted? The mother informs you that there are two older children in the
house, 8 and 9 years old.
9. A 18 year old female asks for the best thing for a yeast infection. She has not had a yeast infection
before. What products can she use if she may be pregnant?
10. B. L. comes in asking your advice with respect to her contact lenses. She is just starting to wear
them again after 1 year. When looking at all the products available now she can't remember what
she used to use.
11. A local day care operator comes to you in a panic. She has 12 children, ages 4 to 8, attending a
summer program and one child was found to have head lice today. The children all share their
clothes, baseball caps and hair bands. What should she tell the parents? What advice do you give
to the individual parents who come to you?
12. A father asks if it is wise to give iron drops to his 4 month old child, as a neighbour said it
promotes good bone development. He also wants to know if he should be taking an iron
supplement. What are the differences between the various formulations and salts?

13. D. L., a local basketball player, says he would like a vitamin to give him more energy. He requests
the very best and says price is no object.
14. A mother comes in for a cough syrup for her diabetic teen. How do you choose a product? Where
would you find this information?
15. R. L. has a puzzled look on his face while standing in front of the cough and cold preparations. She
asks which product line is best and which preparation you would recommend for her cough.
What can you recommend if she is breastfeeding? Has high blood pressure?
16. B. B. comes in complaining of a mild recurrence of his hemorrhoids. What advice and
recommendations would you give B. B.?
17. L. J. has decided to quit smoking. She wants to know which is better: the gum, the patch, or the
inhaler. She would also like to know if there are other alternatives to these products and if she can
use some of the products together. She is concerned that one product alone will not be strong
enough for her to overcome the cravings. She also wants to know if vaping is better.
18. A student with obvious acne on his forehead and chin asks your advice. What general information
would you give? What treatment plan would you make? What counselling would you provide?
The student returns in a week after using a product containing benzoyl peroxide 5%. His acne has
improved but his skin looks sunburned. What questions do you ask? What is your
recommendation?
19. P. Q. asks your advice concerning St. John’s Wort as he wants to go off his prescription
antidepressant. What is your advice to this patient?
20. You have observed that an elderly man has been purchasing a stimulant laxative regularly for
several months. He approaches you today and requests your advice on a product that is stronger
because what he has been using is no longer effective. Given this opportunity, how would you
question and counsel this customer?
21. A customer approaches the dispensary and asks what herbal products you would recommend to
make his cold better before he goes on holidays.
22. A contact lens wearer asks you to recommend a product for his dry eyes. He would like to find
one that he can use with or without contacts.
23. A woman who is 8 months pregnant asks for a laxative and mentions that she also has
hemorrhoids. What products are safe for her to use?
24. A young couple is planning a two week trip to Europe. They don’t want to feel jet-lagged and
ask about melatonin. What information do you provide?
25. An ostomy patient explains to you that he is experiencing irritation around his stoma site.
What general treatment measures and/or products would you recommend?

26. A patient was reading about the link between homocysteine and heart disease. He would like
to take preventative measures and asks about foods that he should add to his diet to increase
his folic acid intake.
27. A patient has recently been diagnosed with Type 2 diabetes and you have discussed the
benefits of monitoring their blood sugar. The patient has a comprehensive insurance plan that
would cover the cost of the monitoring device. Can you issue a prescription for the patient’s
blood sugar monitor, and strips? What are the requirements when issuing a prescription?
What do you do if the patient decides they want to purchase the device elsewhere?
28. Mrs. Brown brings in all her medications in a paper bag and has asked if you could put her
medication in compliance packaging from now on. Mrs. Brown is on some multivitamins as
recommended by her optometrist to help with her macular degeneration. She would like them
included in the blister pack as well. What action can the pharmacist take in order to fulfil Mrs.
Brown’s request?

E. Community Pharmacy Assignment
1. A teenage girl has just spent the day sun tanning at the beach. She is now trying to alleviate the
discomfort of her sunburn. How would you assess the severity of the burn and under what
conditions would you refer her to a doctor?
2. A mother comes in with her baby and 2-year old toddler. They are planning a weeklong vacation
at a cottage on the lake. What recommendations would you give the mother about sunscreens for
the children? What about bug spray?
3. One of your regular patients with arthritis asks you about a cream she just heard about. She says
she can’t remember the name, but thinks it was made from hot peppers. What product is she
referring to? What can you tell her about the product and its use? Are there any other products
you would recommend?
4. A young woman, J. L., confides in you that she is 2 months pregnant. Her midwife has
recommended prenatal vitamins, but J.L. thinks her diet is adequate. What information would you
give her?
5. A middle-aged couple ask about antioxidant vitamins. They are concerned that the food supply is
being contaminated with antibiotics and pesticides. They are also interested in the “heart-
protective” effects of these vitamins. What vitamins are they referring to? What do you suggest?
6. A baby (6 months old) has an upper respiratory tract infection. His mother has been told that the
air is too dry in her son’s room. She does not know whether to buy a cool mist or a warm mist
humidifier. What is the difference between the two and which would you recommend? His
mother also asks where she can find the Vicks Vaporub®, as she thinks that a small amount
applied to the baby’s chest may help relieve his congestion. What could you tell her?
7. A patient comes to the dispensary. He is obviously short of breath, is audibly wheezing and can
hardly speak because of an acute asthmatic attack. He has forgotten his inhaler and asks you give
him one of those “blue puffers” right away. What would you do?
8. A new patient comes to your pharmacy with a discharge prescription for oxycocet® and
erythromycin after having surgery. Upon filling the prescriptions, you check the patient’s DPIN
and discover she is on a daily dose of methadone. What do you do? Whom do you contact? How
is pain managed for a patient on methadone? What medications interact with methadone?
9. A patient brings in a half finished bottle of vitamins. The vitamins were purchased in your
pharmacy just four weeks ago and the product is now outdated. The patient wants his money
back. How would you handle the situation?
10. The husband of a patient you know to be terminally ill comes in at closing on Friday night. His wife
has just run out of Morphine Slow Release 60mg tablets which she has been getting regularly for

the past 8 weeks. On her patient record, you see that the current prescription wasn’t due to run
out for at least another 10 days. What do you do tonight?
11. You see a 9 year old boy in the store by himself who has picked up a bottle of liquid paper cement
and concealed it in his back pack. What do you do?
12. You get a telephone call from a physician’s office and the person on the telephone is giving you
a new prescription for a patient that will be attending your pharmacy. You realize the person
giving the order is not the physician, but is the nurse working in the physician’s office. How do
you handle this situation?
13. You have never handled Suboxone® prescriptions in your pharmacy. A patient, who is unknown to
you, tells you that he is planning on moving into the area and asks if you would dispense his
prescriptions. What is your response?
14. A young woman approaches your pharmacy technician and requests Plan B®. She is referred to
you and during the consultation asks you if there will be any problem with her seizure
medications and if the effectiveness of Plan B will change. What do you tell her?
15. A university student approaches you for Plan B®. The pharmacist on duty with you thinks she
recognizes the student from a few weeks ago when she received Plan B®. During your private
consultation with the young woman she admits that she has used Plan B® three times in the last 2
months and wonders if there are other alternatives as this is very expensive. What are your
recommendations?
16. A nurse practitioner (i.e. an extended practice registered nurse) calls you to prescribe pain
medication for one of her patients. What medications can she/he prescribe depending on the
conditions on the nurse practitioner’s license? How would you verify the prescribing authority
of the nurse practitioner?
17. Describe the process and documentation needed when a pharmacist refuses to fill a Manitoba
Prescribing Practices (M3P) prescription.
18. A patient needs more of a medication, but there are no refills remaining on the prescription.
What would you do when the prescriber has not returned the request for additional refills?
19. A patient attends your pharmacy at closing on a summer Friday night before a long weekend
and requests a refill for a corticosteroid cream she uses for a poison ivy rash she gets
periodically at the cottage. In reviewing her patient profile you note she has 2 refills for the
prescription that are two years old. Neither you nor her will be able to contact the physician
until the following Tuesday and access to a physician on call, emergency room or walk-in clinic
is not possible. What are your options?
(a) Describe if your options change and how, if you know the patient’s medical history?
(b) Describe if your options change and how, if there is no repeat authorization on the
prescription?

(c) Describe if your options change and how, if the prescription is for Tylenol #3 for a
different chronic medical problem and the part fill authorization was two years old?
(d) Describe if your options change and how if the prescription was from another pharmacy
and how, if you can, or cannot contact the other pharmacy?
(e) Which medications have expiry dates on refills?
20. Another pharmacist working in the pharmacy is self-medicating with numerous prescription
drugs for a variety of ailments and taking the medication from stock. What would you do?
21. A young man was working out and “pulled a muscle” in his back. He brings you two products
that look similar, Robaxisal® and Robaxacet®. He asks you which one is better and also wants
to know if there is something stronger available. What advice would you give him?
22. A young woman who is breast-feeding her 3-week old baby is concerned that she doesn’t
seem to have much milk. What do you suggest? She returns a few days later and asks about
infant formulas. What would you recommend? How would you counsel the woman about
preparing the formula and bottles?
23. What is the phone number in your community for the Poison Control Centre? For the non-
emergency police line?
24. Describe two scenarios where you and your preceptor adapted a prescription. What is the
procedure to follow when adapting a prescription?
25. Mr. Smith is a regular patient in your pharmacy and had a heart attack 3 years ago. He was
started on atorvastatin 80mg daily and then the dose was decreased after six months to his
current dose of 20mg daily. Today, Mr. Smith is requesting a refill, but the prescription no
longer has any refills remaining and he is leaving for a month long vacation tomorrow. What
information would you require to be satisfied before renewing a continued care prescription?
What quantity would be dispensed? What documentation and notification are required? Who
is the prescriber on a continued care prescription?
26. Discuss the statement: “Remember the authority to prescribe must never be interpreted to be
an expectation to prescribe”. Describe a scenario whereby a pharmacist may decide to refuse
to prescribe a continued care prescription.
27. You have received your authorization to administrate drugs and vaccinations by injections from
the College. Discuss whether this means you can inject any drug at any time. What are the
limitations in community practice? What are the limitations in hospital practice?
28. Describe the different tasks that a pharmacy technician can undertake compared to a pharmacy
assistant or a pharmacy student. In a pharmacy with a College approved pharmacy technician
final check process, what is the responsibilities of the pharmacy technician, the pharmacy
manager and the pharmacist?

29. A young man comes in to purchase needles and insulin without a prescription. What do you do?
Does it change the way you handle the situation if these products are being used for illicit drug
use?

F. Hospital Pharmacy Assignment
1. It is Wednesday morning and you are reviewing an order that is written for:
 gentamicin 120mg IV load and 100mg IV q12h
 clarithromycin 500mg po q12h
 lisinopril 10mg po od (non-formulary drug at your hospital)
 pilocarpine 4% eye drops (someone just used the last one)
Please outline the steps you would follow in dispensing these medications. How would these
procedures change if it were Saturday evening?
2. Outline the principles of aseptic technique. What differences in technique are required when
working in horizontal and vertical laminar air flow hoods?
3. How are narcotics/controlled drugs distributed in the hospital?
4. Describe the policies, standards and procedures of your hospital and the Department of Pharmacy
regarding investigational drugs.
5. Who are the members of the Pharmacy & Therapeutics Committee and what are their roles?
6. Define the formulary system.
7. What are the principles of total quality improvement? Describe the involvement of the pharmacy
staff in the total quality improvement process.
8. A nurse from the ward calls regarding the compatibility of 2 medications. What other information
would you require from the nurse to answer the question?
9. You receive a chemotherapy order for protocol WXYZ Cycle 1 Day 1 listing drugs and dosages. You
are unfamiliar with the WXYZ protocol. How will you:
(a) get information about the protocol?
(b) ensure that nursing is familiar with the protocol?
(c) ensure that the patient is counselled regarding the chemotherapy?
10. A TPN patient with renal dysfunction has developed hyperkalemia. You receive an order to
decrease the K+ content of the TPN. What changes, if any, would this involve in the manufacturing
process for TPN's in your pharmacy? List monitoring parameters for the patient.
11. What type of drug distribution system is employed in your hospital? List the advantages and
disadvantages compared to other systems.
12. You are working at a small hospital pharmacy. It’s 5:00 p.m. on Friday afternoon and an order
arrives in the pharmacy for M-Eslon® 100mg tablets. This product is currently not included in
your inventory. The patient is being treated for osteosarcoma and has just been transferred to
your centre with a prescription written by the attending oncologist at a tertiary care hospital,

located several hundred miles away. The patient indicates that he received this medication at
the other hospital and it is the only thing that has controlled the pain. You are in a rural town
with no other hospital services. The nearest pharmacy is 30 km away and after phoning the
pharmacist there, you determine the product is not available from him/her. What do you do?
13. You are working evenings at a hospital pharmacy in Winnipeg. At 10:00 p.m., an order arrives in
the pharmacy for an amphotericin B intravenous infusion, which your sterile products
department prepares on a regular basis. You are the only pharmacist on duty with a recently
hired technician. Neither of you has any experience in preparing sterile admixtures. The nurse
on the ward has never prepared amphotericin B before. What do you do?
14. You are working on a Saturday evening and a resident calls the pharmacy to see if you stock
sumatriptan. One of his patients on the ward gets frequent migraines which only respond to
this drug. Sumatriptan is non-formulary at your facility, however you do know there is one
package currently in stock. What would you do?
Would your response be different if the resident were calling from the emergency department
or an outpatient clinic?
15. A nurse calls the pharmacy and tells you she was just injecting phenytoin into a running IV and
the catheter now appears to be occluded. What additional information might you like to know
and what would you tell the nurse?
16. You can’t read the handwriting on a prescription and the prescribing physician has left for the
evening. You call the patient’s nurse, but she informs you that the notes on the chart are
equally illegible. The prescription is either for amoxicillin or ampicillin 2g PO ONCE. How would
you handle this situation?
17. Another pharmacist in your hospital is self-medicating with numerous prescription drugs for a
variety of ailments and taking the medication from stock. What would you do?
18. One of the physicians who you work with on the ward approaches you and tells you she has a
very bad cold and runny nose. She is wondering if you can get her a few Sudafed® to get her
through the day shift. How would you respond? Would your response change if she requested
a one-time dose of celecoxib?
19. While filling a prescription, you notice from the patient’s record that a serious drug interaction
could take place with a concurrent medication. When you contact the doctor, he says he has
many patients taking the same combination and refuses to change the drug regimen. Identify
the issues and possible courses of action available to you.
20. It is the end of your shift, and you are checking one of your patient’s charts when the patient’s
husband approaches you. His wife is a palliative care cancer patient who you have been
following for several weeks. He seems frustrated over the way his wife is being treated, and
feels as if everyone on the care team is ignoring his concerns. He begins to tell you that over

the past 24 hours, his wife’s pain has increased and nothing has been done about it. How
would you approach this situation?
21. List at least 2 reference sources for each of the following types of medication related
questions:
 Pediatric dosages
 IV drug administration
 IV compatibility
 Drug-drug interactions
 Drug side effects
 Drug dosing in renal failure
22. You are screening prescription orders in the dispensary when you suddenly recognize one of
the patient’s names as a former employee of the pharmacy department who retired several
years earlier. By the medications which were ordered, you deduce that your former co-worker
is being treated for some type of cancer. She was a very popular employee and you know the
other pharmacists on duty would love to see her. How would you handle this situation?
23. You are working alone late Friday night in the dispensary and you have 30 minutes left on your
shift when an order for a morphine epidural infusion arrives on your desk. The IV admixture
service of your department prepares all epidural infusions for each patient, however, all of the
staff has gone home for the day. Neither you nor the nurses are familiar with preparing these
types of products. How would you handle this situation?
24. A physician calls you to find out how to obtain rifampin IV. How could he obtain this product
and where would you find the telephone number for the Special Access Program in Ottawa?
25. A physician approaches you on the ward regarding a 7 year old female patient weighing 67 kg,
her serum creatinine is 140 mol/L. He would like to know whether any of the patient’s
medications will require dosage adjustment, and if so, what dose would you recommend. He
would like to start the patient on acyclovir, ranitidine, and diphenhydramine.
26. One of your patients had a pre-phenytoin level drawn this morning which was 12 mcg/mL.
What factors can affect phenytoin levels and how would you determine if this value is
appropriate?
27. You are working the night shift and receive an order from a medical resident for ceftazidime
500mg IV q8h for an 11 month old, 10 kg child. The next dose is due at 0100 hours.
Ceftazidime requires a mandatory Infectious Disease consult for use at your facility, and so you
page the prescribing resident to discuss the order. He informs you that the patient has just
arrived from a small rural hospital by ambulance and was started on the ceftazidime there. He
is reluctant to change the order until he can contact that hospital in the morning to determine
why they started therapy. How could you approach this situation?

28. You review the following order in the dispensary: Calcium chloride for peripheral
administration 5 mmol/kg/24 hours. What additional information do you require in order to fill
this prescription?
29. A patient has just lost his only intravenous access line, but still requires one more dose of
cefotaxime, vancomycin, and gentamicin to complete 7 days of therapy. The physician has
asked the nurse to contact the pharmacy to see if you have any suggestions. What suggestions
could you give the team?
30. You are working the Friday evening shift in the dispensary and receive a call from another
hospital in the area asking if they can purchase some stock from your facility to last them the
weekend. What procedures would you follow to provide them with the following medications:
(a) erythropoietin 4000 units preloaded syringes?
(b) varicella zoster immune globulin?
(c) chloramphenicol ophthalmic solution?
(d) Ritalin SR® tablets?
(e) lorazepam 0.5 mg s/l tablets?
(f) acetazolamide injection?
31. You are on the ward looking at one of your patient’s charts when a physician approaches you.
She would like your opinion regarding some antibiotic levels. One of her patients (67 year old
male, serum creatinine of 122 mol/L) had a gentamicin level of 4.2 mg/L. The physician is
wondering if she should change the dose. What would you recommend to this physician?
Would any additional information be required before making a recommendation?
32. What are the policies regarding potassium injectables, their distribution, and drug storage in your
institution? How does this prevent medication errors?
33. How does the facility respond to incident reports? Is there a review process and who is involved in
that review process?
34. Describe the role of a pharmacy assistant in the Alternate Verification Program as approved by the
Council of the College and/or the role of a pharmacy technician in the Pharmacy Technician Final
Check process approved by the College.
35. Describe the activities in your institution to enable a medication reconciliation program upon
admission and discharge.
36. You have received your certification of authorization to administer injections from the College.
Discuss whether this means you can inject any drug at any time. What are the limitations in
community practice? What are the limitations in hospital practice?
37. C.M. comes into the emergency department and will be admitted for urgent surgery. You check
the patient’s DPIN and discover she is on methadone. How does that impact her discharge when
she is sent home 2 days later?

Checklist for Completion of Internship Program
Once the intern has completed the internship program, a final review of the following
information should be performed with the intern:
1.  Internship Objectives
2.  NAPRA’s Professional Competencies for Canadian Pharmacists
3.  NAPRA’s Model Standards of Practice for Canadian Pharmacists
4.  Guide to Pharmacy Practice in Manitoba
5.  The College of Pharmacists Website (www.cphm.ca)
6.  Completion of a minimum of 400 hours of direct patient care
7.  Intern’s Self-Assessment
8.  Complete the DPRP
9.  Complete the Case Scenarios and Questions
10.  Submission of Evaluation feedback and completion forms
Checklist for Completion of Internship 91

Evaluation Forms
92
Phone (204) 233-1411 | Fax: (204) 237-3468
Evaluation Form #1
(Please use the online form through your Member Homepage)
Intern Name: ______________________________________________________
Internship Start Date: _______________ Part 1 End Date: _______________
Today’s Date: ________________
This form is to be completed by the preceptor after the first one-third of the internship hours.
Please submit online to the College office within 7 days of completion of the first 200 (or 120)
hours.
Use the comments section to provide feedback and justification for your evaluation.
Please use the following rating scale to gauge the intern’s performance in the competency
areas:
RATING SCALE
Intern’s knowledge to perform the task is below expectations. Intern requires
1 Unsatisfactory assistance and extensive intervention and support to complete the task.
Demonstrates objective < 60% of the time.
Intern has the knowledge and understands process, but does not always apply them
Needs
2 consistently and independently without supervision. Frequently requires support.
Improvement
Demonstrates objective 60% to < 75% of the time.
Intern can perform task independently and with confidence. Requires only occasional
3 Satisfactory
support. Demonstrates objective > 75% of the time.
Intern can perform in an independent fashion. Rarely needs support. No
4 Exemplary improvement needed. Always above expectations.
Demonstrates objective > 90% of the time.
N/O No opportunity No opportunity to experience the competency element in previous work experience.
Evaluation Form #1 93
Phone (204) 233-1411 | Fax: (204) 237-3468

Key Competency Please rate the intern’s performance in the following areas: Rating
1 2 3 4 N/O
potential illegal,
unethical, or Is able to appropriately identify and address illegal, unethical or
1 2 3 4 N/O
unprofessional actions unprofessional actions or situations.
or situations in the
workplace.
professionalism.
1 2 3 4 N/O
Is able to assess own learning needs and develop a learning plan
1 2 3 4 N/O
accordingly.
public.
1 2 3 4 N/O
1.5 Document
legislation, standards not be shared, as well as the appropriate methods with which to 1 2 3 4 N/O
COMMENTS:
Phone (204) 233-1411 | Fax: (204) 237-3468

patient.
relationship.
1 2 3 4 N/O
1 2 3 4 N/O
medication.
2.4 Determine the
problems.
timeframes.
1 2 3 4 N/O
care plan.
1 2 3 4 N/O
2.6 Implement the Undertakes actions outlined in the care plan, including:
patient’s care plan. 1 2 3 4 N/O
prescribing, adapting prescriptions.
Phone (204) 233-1411 | Fax: (204) 237-3468

the necessary Administers drugs by injection, or another appropriate route, using
technical skills and the necessary technical skills and applying the appropriate clinical 1 2 3 4 N/O
applying the knowledge, if authorized to do so.
appropriate clinical
knowledge.
outcomes. monitoring parameters and timelines.

1 2 3 4 N/O
COMMENTS:

the patient.
1 2 3 4 N/O
documentation).

1 2 3 4 N/O
and implements measures to prevent occurrences or
reoccurrences.


1 2 3 4 N/O
Phone (204) 233-1411 | Fax: (204) 237-3468

COMMENTS:

patient care.
efficiency of care.
operations in the
care.
inventory to ensure 1 2 3 4 N/O
recalled, expired and unusable products.
audits regularly.
COMMENTS:
Phone (204) 233-1411 | Fax: (204) 237-3468

and populations.
1 2 3 4 N/O
with the patient. environment that are barriers to, or facilitators of, health and
1 2 3 4 N/O
1 2 3 4 N/O
5.2 Participate in
activities.
maintenance of a
healthy environment
for the public.
COMMENTS:

care.
practice.
professional
judgement to the
1 2 3 4 N/O
1 2 3 4 N/O
questions using reliable and relevant information.
COMMENTS:
Phone (204) 233-1411 | Fax: (204) 237-3468

7.1 Establish and
techniques.

1 2 3 4 N/O
communicating.
communication
7.3 Deliver an
1 2 3 4 N/O
group.
COMMENTS:

8.1 Create and
1 2 3 4 N/O
relationships.
effectiveness of
Interacts respectfully with other members of the team by 1 2 3 4 N/O
accepting accountability for themselves and managing
Phone (204) 233-1411 | Fax: (204) 237-3468
so.
COMMENTS:

safety.
1 2 3 4 N/O
workplace team.
patient at risk.
management.
maintain a working
promotes safety.
1 2 3 4 N/O
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468
INTERN’S COMMENTS:
Signature: _______________________ _____________________

Preceptor Intern
Print Name: _______________________ _____________________

Preceptor Intern

Phone (204) 233-1411 | Fax: (204) 237-3468
Evaluation Form #2
Intern Name: _____________________________________________________
Part 2 Start Date: _______________ Part 2 End Date: _____________
Today’s Date: ________________
This form is to be completed by the preceptor after the second third of the internship hours.
Please submit online to the College office within 7 days of completion of the second 200 (or
120) hours.
areas:
RATING SCALE
Needs
Improvement
3 Satisfactory
N/O No opportunity No opportunity to experience the competency element in previous work experience.

Phone (204) 233-1411 | Fax: (204) 237-3468

1 2 3 4 N/O
potential illegal,
unethical, or
unprofessional actions Is able to appropriately identify and address illegal, unethical or
1 2 3 4 N/O
or situations in the unprofessional actions or situations.
workplace.
professionalism.
1 2 3 4 N/O
1 2 3 4 N/O
accordingly.
public.
1 2 3 4 N/O
1.5 Document
legislation, standards not be shared, as well as the appropriate methods with which to 1 2 3 4 N/O
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468

patient.
relationship.
1 2 3 4 N/O
1 2 3 4 N/O
medication.
2.4 Determine the
problems.
timeframes.
1 2 3 4 N/O
care plan.
1 2 3 4 N/O
2.6 Implement the Undertakes actions outlined in the care plan, including prescribing
patient’s care plan. and adapting prescriptions. 1 2 3 4 N/O

Phone (204) 233-1411 | Fax: (204) 237-3468

knowledge.
outcomes.
1 2 3 4 N/O
effectiveness and revising when necessary.
COMMENTS:

the patient.
1 2 3 4 N/O
documentation).

1 2 3 4 N/O
and implementing measures to prevent occurrences or
reoccurrences.


1 2 3 4 N/O

Phone (204) 233-1411 | Fax: (204) 237-3468

COMMENTS:

patient care.
efficiency of care.
operations in the
care.
inventory to ensure 1 2 3 4 N/O
audits regularly.
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468

and populations.
with the patient. 1 2 3 4 N/O
1 2 3 4 N/O
1 2 3 4 N/O
agencies and health services
5.2 Participate in
activities.
maintenance of a
healthy environment
for the public.
COMMENTS:

care.
practice.
professional
judgement to the
1 2 3 4 N/O
1 2 3 4 N/O
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468

7.1 Establish and
techniques.

1 2 3 4 N/O
communicating.
communication
7.3 Deliver an
1 2 3 4 N/O
group.
COMMENTS:

8.1 Create and
1 2 3 4 N/O
relationships.
effectiveness of
accepting accountability for themselves and managing 1 2 3 4 N/O

Phone (204) 233-1411 | Fax: (204) 237-3468
so.
COMMENTS:

safety.
1 2 3 4 N/O
workplace team.
patient at risk.
management.
maintain a working
promotes safety.
1 2 3 4 N/O
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468
Signature: _______________________ _____________________

Preceptor Intern
Print Name: _______________________ _____________________

Preceptor Intern

Phone (204) 233-1411 | Fax: (204) 237-3468
Final Evaluation Form

(Please use the online form on your Member Homepage)
Intern Name: _____________________________________________________
Part 3 Start Date: _______________ Part 3 End Date: ____________
Today’s Date: ________________
This form is to be completed by the preceptor after the completion of the 600 (or 360) hour
internship. Please submit online to the College office within 7 days of completion of the
internship.
areas:
RATING SCALE
Needs
Improvement
3 Satisfactory
Note: Interns must achieve a rating of satisfactory or exemplary in all areas of the Final
Evaluation before they can successfully complete the internship program.
Final Evaluation Form 111

Phone (204) 233-1411 | Fax: (204) 237-3468

legal requirements. health and safety legislation, privacy legislation, federal and 1 2 3 4
principles. 1 2 3 4
1 2 3 4
potential illegal,
unethical, or
unprofessional actions Is able to identify and appropriately address illegal, unethical or
1 2 3 4
or situations in the unprofessional actions or situations.
workplace.
1.4 Apply principles of Accepts responsibility for own actions and decisions. 1 2 3 4
professionalism.
1 2 3 4
1 2 3 4
accordingly.
Exhibits professionalism in appearance, attitude and punctuality. 1 2 3 4
with the staff, peers, other healthcare professionals, and the 1 2 3 4
public.
Protects the privacy and confidentiality of the patient. 1 2 3 4
Identifies and manages situations of conflict of interest. 1 2 3 4
1 2 3 4
1.5 Document
Maintains complete, accurate and secure patient records. 1 2 3 4
legislation, standards not be shared, as well as the appropriate method with which to 1 2 3 4
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468

professional 1 2 3 4
Demonstrates a caring, empathetic, and professional attitude. 1 2 3 4
patient.
health care goals and respects the roles of each party in the 1 2 3 4
relationship.
information about the information, by actively listening and interpreting information 1 2 3 4
patient’s health status by the patient, considering the impact of factors such as culture, 1 2 3 4
1 2 3 4
Performs medication reconciliation. 1 2 3 4
1 2 3 4
medication.
2.4 Determine the
problems and consults with the patient and, if necessary, other 1 2 3 4
problems.
patient’s care plan. outcomes, specifying measurable endpoints, target values and 1 2 3 4
timeframes.
1 2 3 4
to support the patient in making informed decisions about their 1 2 3 4
care plan.
1 2 3 4
Assesses the patient’s understanding of the therapeutic plan. 1 2 3 4
2.6 Implement the 1 2 3 4
Undertakes actions outlined in the care plan, including prescribing
patient’s care plan. and adapting prescriptions.

Phone (204) 233-1411 | Fax: (204) 237-3468

knowledge.
assess therapeutic 1 2 3 4
outcomes.
ii) Assessing adherence, tolerance and safety of therapy. 1 2 3 4
1 2 3 4
COMMENTS:

safely and accurately 1 2 3 4
the patient.
bio-equivalency, therapeutic equivalency, interchangeability, 1 2 3 4
1 2 3 4
documentation).
Is able to supervise support staff during drug distribution activities. 1 2 3 4

1 2 3 4
and implementing measures to prevent occurrences or
reoccurrences.

compounds non-sterile products according to recognized 1 2 3 4

1 2 3 4

Phone (204) 233-1411 | Fax: (204) 237-3468

prescription using a systematic approach, including an 1 2 3 4
COMMENTS:

patient care.
safety, efficacy and necessary to effectively prioritize, organize and manage patient 1 2 3 4
efficiency of care.
operations in the
practice setting. 1 2 3 4
practice setting on the safety, efficacy and efficiency of patient 1 2 3 4
care.
inventory to ensure 1 2 3 4
efficient patient care. 1 2 3 4
are met. For example cold chain is maintained, drug shortages and 1 2 3 4
audits regularly.
ensure safe, effective permanence of records in the practice setting. Addresses any 1 2 3 4
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468

and populations.
with the patient. 1 2 3 4
1 2 3 4
1 2 3 4
5.2 Participate in
public health 1 2 3 4
activities.
maintenance of a
drugs and hazardous materials. Identifies and minimizes the risk of 1 2 3 4
healthy environment
for the public.
COMMENTS:

care.
research skills and 1 2 3 4
practice.
professional
Makes decisions using an evidence-based approach. 1 2 3 4
judgement to the
1 2 3 4
1 2 3 4
composes an appropriate response to the question. Ensures that 1 2 3 4
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468

7.1 Establish and
maintain effective Demonstrates proficiency in written and verbal English or French. 1 2 3 4
verbal, non-verbal and listening skills and effective interview 1 2 3 4
techniques.

1 2 3 4
communicating.
effective and including repeating back verbal orders, using recognized 1 2 3 4
communication
systems. 1 2 3 4
information that can be retrieved by relevant personel.
7.3 Deliver an
1 2 3 4
group.
COMMENTS:

8.1 Create and
1 2 3 4
relationships.
Demonstrates leadership qualities in team activities. 1 2 3 4
effectiveness of
working relationships Shares decision-making activities with other team members. 1 2 3 4
accepting accountability for themselves and managing 1 2 3 4

Phone (204) 233-1411 | Fax: (204) 237-3468
collaborative health 1 2 3 4
services. 1 2 3 4
so.
COMMENTS:

culture of patient 1 2 3 4
safety.
1 2 3 4
workplace team.
continuous quality 1 2 3 4
patient at risk.
related to pharmacy event or close call and responds effectively to mitigate harm and 1 2 3 4
products. 1 2 3 4
management.
9.4 Create and Minimizes and manages distractions in the work environment. 1 2 3 4
maintain a working
environment that 1 2 3 4
promotes safety.
1 2 3 4
COMMENTS:

Phone (204) 233-1411 | Fax: (204) 237-3468
Signature: _______________________ _____________________

Preceptor Intern
Print Name: _______________________ _____________________

Preceptor Intern

Phone (204) 233-1411 | Fax: (204) 237-3468
Intern’s Evaluation of the Preceptor

Intern Name: _____________________ Date: _______________
Preceptor Name: __________________ Date: _______________
Please use the following rating scale to assess your preceptor’s performance in the following
areas. Provide any comments or justifications to your answers in the comments section.
1 2 3 4
Unsatisfactory Needs Improvement Satisfactory Exemplary
Please rate the preceptor’s performance in the following areas: 1 2 3 4

Was prepared for the rotation and was familiar with the expectations and activities of the
   
internship.
Provided an orientation to the site and staff members.    
Treated me with respect.    
Acted professionally and ethically.    
Was available to answer questions or participate in discussion.    
Encouraged active participation and involved me in appropriate decision making situations
   
under supervision.
Provided constructive feedback throughout the rotation and suggested areas of
   
improvement.
Provided opportunities to learn or improve upon all the required skills.    
Constructively reviewed my Evaluations with me throughout the internship.    
Provided me with the necessary opportunities and patient interactions to complete the
   
internship Objectives.
COMMENTS:
Intern: ___________________________ _________________________

Signature Print Name
Intern’s Evaluation of the Preceptor 120

Phone (204) 233-1411 | Fax: (204) 237-3468
Intern’s Feedback on the Internship Program

Intern Name: _______________________________ Date: ________________
Preceptor Name: ____________________________
Pharmacy Name: _______________________________
In order to assess the Internship Program and Manual, please check off the appropriate boxes:
Please agree or disagree with the following statements Strongly Strongly

Disagree Neutral Agree
about the Internship Manual and Program below: Disagree Agree
The Internship Manual was relevant to pharmacy practice.     
The Internship Manual was well organized and easy to use.     

The Internship Manual contained just the right level of
information and depth.     
The internship program was a valuable experience.     

COMMENTS:
To help us improve the internship program, please answer the following questions and provide
comments
1. Was the internship of sufficient length?
2. Do you feel the program improved your competence and confidence?
3. How would you improve the internship program?
4. How would you improve the Internship Manual? Did you find any typos or errors in the
Internship Manual? (Please provide page numbers).
5. Please provide any additional comments on the internship program, manual, and
evaluation forms.
Intern: _____________________________ _________________________

Intern’s Feedback on the Internship Program 121

Phone (204) 233-1411 | Fax: (204) 237-3468
Preceptor’s Feedback on the Internship Program

(Please use the online form on your Member Homepage)
Intern Name: _______________________________ Date: ________________
Preceptor Name: _______________________________
Pharmacy Name: _______________________________
In order to assess the Internship Program and Manual, please check off the appropriate boxes:
Please agree or disagree with the following statements Strongly Strongly

Disagree Neutral Agree
about the Internship Manual and Program below: Disagree Agree
The Internship Manual was relevant to pharmacy practice.     
The Internship Manual was well organized and easy to use.     

The Internship Manual contained just the right level of
information and depth.     
The internship program was a valuable experience.     

COMMENTS:
To help us improve the internship program, please answer the following questions and provide
comments:
1. Was the internship of sufficient length?
2. Do you feel the program improved the intern’s competence and confidence?
3. How would you improve the internship program?
4. How would you improve the Internship Manual? Did you find any typos or errors in the
Internship Manual? (Please provide page numbers).
5. Please provide any additional comments on the internship program, manual, and
evaluation forms.
Preceptor: ___________________________ __________________________

Preceptor’s Feedback on the Internship Program 122

Phone (204) 233-1411 | Fax: (204) 237-3468
E-mail: [email protected] | Website:www.cphm.ca
Statement of Completion of Internship

Please sign the appropriate statement:
I hereby declare that ______________________________ has successfully completed

Name of pharmacy intern
all requirements and overall objectives as identified by the College of Pharmacists of
Manitoba Internship Program and has adequately demonstrated all nine competency
areas including the completion of the Demonstration of Product Release Proficiency and,
in my opinion, is fit to practice as a pharmacist competently, safely, and ethically and is
hereby recommended to be registered and licensed to practice Pharmacy in Manitoba.
Preceptor Signature: ________________________ Date: ________________
I hereby declare that____________________________________ has not successfully

completed all requirements and overall objectives as identified by the College of
Pharmacists of Manitoba Internship Program and has not adequately demonstrated all
nine competency areas, including the completion of the Demonstration of Product
Release Proficiency, and in my opinion, is not fit to practice as a pharmacist competently,
safely and ethically. I do NOT recommend that the above intern be registered and
licensed to practice Pharmacy in Manitoba.
I hereby request that _________________________________ be reviewed by another

preceptor, approved by the College of Pharmacists of Manitoba, for a period of at least
40 hours and, upon completion, I will be available to consult with the other preceptor and
decide which “statement of completion” is appropriate for this candidate.
Statement of Completion 123

Phone (204) 233-1411 | Fax: (204) 237-3468
E-mail: [email protected] | Website:www.cphm.ca
Letter to Preceptors from the College of Pharmacists of Manitoba

Dear Pharmacist:
The College of Pharmacists of Manitoba has designated participation as a preceptor for pharmacy
students, residents, interns and technicians to be an accredited learning activity for pharmacists in
Manitoba.
Pharmacists may document their significant learning experiences and contact learning time gained through
their involvement in the preceptorship in their Online Professional Development (PD) Log. For example, if the
pharmacy student was giving a case presentation and in preparation for that presentation, the preceptor
reviewed recent literature on the subject, he/she could then document the time spent learning as an
accredited learning activity. The preceptor would then document in the Professional Development Log the
following:
 that the learning activity was an accredited learning activity;
 that the learning activity was a preceptorship accredited by the College;
 the assigned College accreditation file number;
 the reference of the individual articles reviewed;
 the time taken to review the articles, and
 the key ideas, thoughts, or learning points gained through the learning experience.
At the completion of the preceptorship, pharmacists may calculate the total number of continuing
education units (CEUs) obtained through active learning as a preceptor and enter this number on the
accreditation statement. For the purposes of calculation, involvement in one contact hour of an
accredited learning activity is equivalent to one CEU. Pharmacists can only claim as much time as was
spent doing active learning/research with the intern, and these activities need to be documented. The
accreditation statement may be kept in your PD Log as a record of your involvement as a preceptor.
If you have any questions regarding the documentation procedure for preceptorships in the College
Learning Portfolio, please do not hesitate to contact me directly.
On behalf of The College of Pharmacists of Manitoba, thank you for becoming a preceptor and sharing
your expertise with your colleagues. You have made a very valuable contribution to our profession.
Sincerely,
Kim McIntosh, B.Sc.Pharm.

Assistant Registrar-Qualifications and Practice Development
124
PROFESSIONALDEVELOPMENT
Phone (204) 233-1411 | Fax: (204) 237-3468
Statement of Participation
Name:
Licence Number:
The College has accredited the following program:
Date Participated as a Preceptor for CEU Accreditation

Claimed Number
30192M
This program is designated an accredited learning activity by the College of Pharmacists of

Manitoba for pharmacists in Manitoba.
Pharmacists may document their significant learning experiences personally gained through involvement
in the preceptorship in their PD Log and the contact time associated with the learning. At the completion
of the preceptorship, pharmacists may calculate the total number of continuing education units (CEUs)
obtained through participation as a preceptor and enter this number on the accreditation certificate. For
the purposes of calculation, involvement in one contact hour of an accredited learning activity is
equivalent to one CEU.
Pharmacists can only claim as much time as was spent doing active learning/research with the student
or intern, and these activities need to be documented.
Signature of Preceptor
Kim McIntosh, B.Sc.Pharm.

Assistant Registrar
College Mission: To protect the health and well being of the public by
ensuring and promoting safe, patient-centred and progressive pharmacy practice.
125

Sample Internship Training Plan Template

Uploaded by

Copyright:

Available Formats

Sample Internship Training Plan Template

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Sample Internship Training Plan Template

Uploaded by

Copyright:

Available Formats

What is the purpose of the internship program?

What is the purpose of the internship program?

What are preceptors required to submit to the College?

What are preceptors required to submit to the College?

Internship Manual

Updated February 2018

To be reviewed by the preceptor and intern.

College of Pharmacists of Manitoba Mission:

Once again, thank you for your participation.

Susan Lessard-Friesen, B.Sc. (Pharm.)

College of Pharmacists of Manitoba Mission:

1. Ethical, Legal and Professional Responsibilities

1. Expertise in medications and medication-use

3. Safety and Quality

4. Professionalism and Ethics

The education received during the internship is accomplished by a combination of explanation,

 Order the results of a screening or diagnostic test specified in Schedule 1 to the

 Apply for registration as an extended practice pharmacist.

Expanded Pharmacy Practice Roles 8

Expanded Pharmacy Practice Roles 9

Rules Governing Practice

The College of Pharmacists of Manitoba 18

The College of Pharmacists of Manitoba 19

Orientation to the Pharmacy 20

Orientation to the Pharmacy 21

Orientation to the Pharmacy 22

Orientation to the Pharmacy 23

Orientation to the Pharmacy 24

Professional Competencies for Canadian Pharmacists at Entry to Practice 25

Statement I Pharmacists shall maintain a high standard of professional competence

Statement II Pharmacists shall cooperate with colleagues and other healthcare

Ethical, Legal and Professional Responsibilities 26

Statement VIII Pharmacists shall act with honesty and integrity.

Statement IX Pharmacists shall respect the rights of patients to receive healthcare.

Statement X Pharmacists shall respect and honour the profession of pharmacy.

Pharmacists’ refusal to fill and obligation to provide patient care

According to the Standards of Practice (Section 1.9):

Ethical, Legal and Professional Responsibilities 27

1. Focus on the patient, rather than on the drug(s) or disease(s)

Overview of the Pharmaceutical Care Process

Pharmaceutical Care Plan

Drug Therapy Problems

There are seven possible classifications of drug therapy problems:

Implementing the Patient’s Care Plan

 Prescribing - Pharmacists may only issue a prescription after conducting a patient

o Unscheduled drugs can be sold without professional supervision. Adequate information

When a patient consults the pharmacist for a recommendation on a non-prescription product,

 Obtain feedback regarding the patient’s understanding of the recommendations and

 Encourage appropriate follow-up on the patient’s response to the non-prescription drug

1. Checking for completeness of information

2. Checking the prescriber information

4. Check patient records

The pharmacist may adapt the prescription if:

7. Selecting container and labelling the product

8. Selecting the medication and transferring to container

9. Permission for substitution

10. Pricing the prescription and third party payers

11. Releasing the medication to the patient

13. Refilling a prescription

14. Medication errors